|
OMIM |
Link |
Information gain |
01 |
|
MRX1
|
[NCBI]
|
0.01411992
|
|
|
RA
|
[NCBI]
|
0.01326152
|
|
|
CGF1
|
[NCBI]
|
0.01193635
|
|
|
leber optic atrophy, susceptibility to
|
[NCBI]
|
0.00950767
|
|
|
SLE
|
[NCBI]
|
0.00812122
|
|
|
ALD
|
[NCBI]
|
0.00800713
|
|
|
SCAX1
|
[NCBI]
|
0.00794494
|
|
|
MAFD2
|
[NCBI]
|
0.0066744
|
|
|
MRX3
|
[NCBI]
|
0.0066173
|
|
|
CF
|
[NCBI]
|
0.00597913
|
|
|
THAS
|
[NCBI]
|
0.00584413
|
|
|
fragile x mental retardation syndrome
|
[NCBI]
|
0.0054955
|
|
|
arthrogryposis multiplex congenita, distal, x-linked
|
[NCBI]
|
0.00529104
|
|
|
HBFQTL3
|
[NCBI]
|
0.00529104
|
|
|
dandy-walker malformation with mental retardation, basal ganglia disease, and seizures
|
[NCBI]
|
0.00529104
|
|
|
MRX23
|
[NCBI]
|
0.00529104
|
|
|
HYPX
|
[NCBI]
|
0.00521732
|
|
|
IP
|
[NCBI]
|
0.00508577
|
|
|
MTM1
|
[NCBI]
|
0.00500673
|
|
|
MEAX
|
[NCBI]
|
0.00491159
|
|
|
ND
|
[NCBI]
|
0.00447299
|
|
|
AIC
|
[NCBI]
|
0.0042057
|
|
|
spatial visualization, aptitude for
|
[NCBI]
|
0.0041711
|
|
|
MRX2
|
[NCBI]
|
0.0039662
|
|
|
wieacker syndrome
|
[NCBI]
|
0.0039662
|
|
|
MRX20
|
[NCBI]
|
0.0039662
|
|
|
cowchock syndrome
|
[NCBI]
|
0.0039662
|
|
|
RTT
|
[NCBI]
|
0.00378032
|
|
|
AMMECR1
|
[NCBI]
|
0.00354327
|
|
|
DFN4
|
[NCBI]
|
0.00354327
|
|
|
BTK
|
[NCBI]
|
0.00354204
|
|
|
DMD
|
[NCBI]
|
0.00351377
|
|
|
WAS
|
[NCBI]
|
0.00347356
|
|
|
ED1
|
[NCBI]
|
0.00342904
|
|
|
DFN2
|
[NCBI]
|
0.00342328
|
|
|
EDMD
|
[NCBI]
|
0.00340528
|
|
|
RP3
|
[NCBI]
|
0.00327933
|
|
|
MEHMO
|
[NCBI]
|
0.00304888
|
|
|
RP6
|
[NCBI]
|
0.00304888
|
|
|
RP24
|
[NCBI]
|
0.00304888
|
|
|
MYP1
|
[NCBI]
|
0.00304888
|
|
|
XIST
|
[NCBI]
|
0.00293902
|
|
|
MCOPS1
|
[NCBI]
|
0.0029236
|
|
|
PMD
|
[NCBI]
|
0.00285897
|
|
|
SMAX1
|
[NCBI]
|
0.00284184
|
|
|
HIGM1
|
[NCBI]
|
0.00275981
|
|
|
HPCX
|
[NCBI]
|
0.00271167
|
|
|
ATRX
|
[NCBI]
|
0.00267169
|
|
|
CMTX1
|
[NCBI]
|
0.00266819
|
|
|
CMTX2
|
[NCBI]
|
0.00264274
|
|
|
brooks-wisniewski-brown syndrome
|
[NCBI]
|
0.00264274
|
|
|
MGC1
|
[NCBI]
|
0.00264274
|
|
|
MRX50
|
[NCBI]
|
0.00264274
|
|
|
PRS
|
[NCBI]
|
0.00264274
|
|
|
MRXS7
|
[NCBI]
|
0.00264274
|
|
|
parkinsonism, early-onset, with mental retardation
|
[NCBI]
|
0.00264274
|
|
|
EFMR
|
[NCBI]
|
0.00260275
|
|
|
CHM
|
[NCBI]
|
0.00257639
|
|
|
XLP1
|
[NCBI]
|
0.00256621
|
|
|
SGBS1
|
[NCBI]
|
0.00256199
|
|
|
ichthyosis, x-linked
|
[NCBI]
|
0.00254597
|
|
|
CSNB1A
|
[NCBI]
|
0.00251613
|
|
|
CLS
|
[NCBI]
|
0.00251291
|
|
|
CGD
|
[NCBI]
|
0.00249997
|
|
|
CDPX2
|
[NCBI]
|
0.00248942
|
|
|
masa syndrome
|
[NCBI]
|
0.00242483
|
|
|
SPG16
|
[NCBI]
|
0.002284849
|
|
|
PDR
|
[NCBI]
|
0.002284849
|
|
|
CMTX3
|
[NCBI]
|
0.002284849
|
|
|
CVD1
|
[NCBI]
|
0.002284849
|
|
|
AD
|
[NCBI]
|
0.002282147
|
|
|
MCOPS7
|
[NCBI]
|
0.0022544
|
|
|
OKS
|
[NCBI]
|
0.00224347
|
|
|
ehlers-danlos syndrome, type v
|
[NCBI]
|
0.002224613
|
|
|
terminal osseous dysplasia and pigmentary defects
|
[NCBI]
|
0.002224613
|
|
|
CBBM
|
[NCBI]
|
0.00219028
|
|
|
ADFN
|
[NCBI]
|
0.002180181
|
|
|
PHP
|
[NCBI]
|
0.002178918
|
|
|
CPX
|
[NCBI]
|
0.002151558
|
|
|
HSAS
|
[NCBI]
|
0.002128835
|
|
|
deafness, conductive, with stapes fixation
|
[NCBI]
|
0.002048404
|
|
|
BZX
|
[NCBI]
|
0.001973014
|
|
|
ATS
|
[NCBI]
|
0.001970849
|
|
|
SCIDX1
|
[NCBI]
|
0.001958482
|
|
|
MRXHF1
|
[NCBI]
|
0.001946832
|
|
|
RP2
|
[NCBI]
|
0.001920341
|
|
|
menkes disease
|
[NCBI]
|
0.001916533
|
|
|
FGS2
|
[NCBI]
|
0.001866722
|
|
|
WTS
|
[NCBI]
|
0.001866722
|
|
|
graves disease, susceptibility to, x-linked
|
[NCBI]
|
0.001866722
|
|
|
mental retardation with optic atrophy, deafness, and seizures
|
[NCBI]
|
0.001866722
|
|
|
MCOPS4
|
[NCBI]
|
0.001866722
|
|
|
BTHS
|
[NCBI]
|
0.001852772
|
|
|
bullous dystrophy, hereditary macular type
|
[NCBI]
|
0.001683358
|
|
|
hyperglycerolemia
|
[NCBI]
|
0.001669686
|
|
|
hypophosphatemic rickets, x-linked dominant
|
[NCBI]
|
0.001645048
|
|
|
hypertelorism with esophageal abnormality and hypospadias
|
[NCBI]
|
0.001618891
|
|
|
diabetes mellitus, insulin-dependent, x-linked, susceptibility to
|
[NCBI]
|
0.001603117
|
|
|
AHC
|
[NCBI]
|
0.001572656
|
|
|
L1CAM
|
[NCBI]
|
0.001552922
|
|
|
TKCR
|
[NCBI]
|
0.001525672
|
|
|
ichthyosis follicularis, atrichia, and photophobia syndrome
|
[NCBI]
|
0.001525672
|
|
|
DMD
|
[NCBI]
|
0.001515796
|
|
|
properdin deficiency, x-linked
|
[NCBI]
|
0.001495948
|
|
|
NHS
|
[NCBI]
|
0.001427159
|
|
|
x inactivation, familial skewed, 2
|
[NCBI]
|
0.001419753
|
|
|
BFLS
|
[NCBI]
|
0.001418837
|
|
|
mucopolysaccharidosis type ii
|
[NCBI]
|
0.001386776
|
|
|
G6PD
|
[NCBI]
|
0.001368505
|
|
|
immunoglobulin m, level of
|
[NCBI]
|
0.00134032
|
|
|
AIED
|
[NCBI]
|
0.001332643
|
|
|
IPEX
|
[NCBI]
|
0.001326925
|
|
|
wittwer syndrome
|
[NCBI]
|
0.001320683
|
|
|
MRX72
|
[NCBI]
|
0.001320683
|
|
|
abidi x-linked mental retardation syndrome
|
[NCBI]
|
0.001320683
|
|
|
MRX52
|
[NCBI]
|
0.001320683
|
|
|
XGR
|
[NCBI]
|
0.001320683
|
|
|
MCS
|
[NCBI]
|
0.001320683
|
|
|
AMCX5
|
[NCBI]
|
0.001320683
|
|
|
MRXS11
|
[NCBI]
|
0.001320683
|
|
|
MRX29
|
[NCBI]
|
0.001320683
|
|
|
martin-probst deafness-mental retardation syndrome
|
[NCBI]
|
0.001320683
|
|
|
MRX73
|
[NCBI]
|
0.001320683
|
|
|
MRXS12
|
[NCBI]
|
0.001320683
|
|
|
amelogenesis imperfecta, hypoplastic/hypomaturation, x-linked 2
|
[NCBI]
|
0.001320683
|
|
|
MRX53
|
[NCBI]
|
0.001320683
|
|
|
EMWX
|
[NCBI]
|
0.001320683
|
|
|
MRX82
|
[NCBI]
|
0.001320683
|
|
|
DFN6
|
[NCBI]
|
0.001320683
|
|
|
RP23
|
[NCBI]
|
0.001320683
|
|
|
MCOPCB1
|
[NCBI]
|
0.001320683
|
|
|
CORDX2
|
[NCBI]
|
0.001320683
|
|
|
AGMX2
|
[NCBI]
|
0.001320683
|
|
|
MRX42
|
[NCBI]
|
0.001320683
|
|
|
armfield x-linked mental retardation syndrome
|
[NCBI]
|
0.001320683
|
|
|
immunoneurologic disorder, x-linked
|
[NCBI]
|
0.001320683
|
|
|
coronary heart disease, susceptibility to, 3
|
[NCBI]
|
0.001320683
|
|
|
migraine, familial typical, susceptibility to, 2
|
[NCBI]
|
0.001297091
|
|
|
HTC2
|
[NCBI]
|
0.001297091
|
|
|
CDPX1
|
[NCBI]
|
0.001267614
|
|
|
CORDX1
|
[NCBI]
|
0.001264497
|
|
|
NDP
|
[NCBI]
|
0.001256658
|
|
|
CRC
|
[NCBI]
|
0.001243612
|
|
|
RS1
|
[NCBI]
|
0.001232182
|
|
|
SXI1
|
[NCBI]
|
0.001231185
|
|
|
RPGR
|
[NCBI]
|
0.001229712
|
|
|
HBD
|
[NCBI]
|
0.001205488
|
|
|
BMD
|
[NCBI]
|
0.001199085
|
|
|
TNF
|
[NCBI]
|
0.001154137
|
|
|
PDHA1
|
[NCBI]
|
0.001096368
|
|
|
EGF
|
[NCBI]
|
0.00109326
|
|
|
VEGF
|
[NCBI]
|
0.001091693
|
|
|
MRXS13
|
[NCBI]
|
0.001091591
|
|
|
DYT3
|
[NCBI]
|
0.001077559
|
|
|
ptosis, hereditary congenital 2
|
[NCBI]
|
0.001062917
|
|
|
testicular germ cell tumor 1
|
[NCBI]
|
0.001062917
|
|
|
spondyloepiphyseal dysplasia tarda, autosomal recessive
|
[NCBI]
|
0.001062917
|
|
|
SEDT
|
[NCBI]
|
0.001039833
|
|
|
OFD8
|
[NCBI]
|
0.00101997
|
|
|
KFSD
|
[NCBI]
|
0.001013668
|
|
|
faciogenital dysplasia
|
[NCBI]
|
0.001003855
|
|
|
ISS
|
[NCBI]
|
0.001002378
|
|
|
neural tube defects, x-linked
|
[NCBI]
|
0.000997634
|
|
|
anemia, sideroblastic, x-linked
|
[NCBI]
|
0.000992575
|
|
|
AHDS
|
[NCBI]
|
0.000985929
|
|
|
RP
|
[NCBI]
|
0.000984301
|
|
|
ATRX
|
[NCBI]
|
0.000975401
|
|
|
GJB1
|
[NCBI]
|
0.000956455
|
|
|
KAL1
|
[NCBI]
|
0.000946052
|
|
|
ABCD1
|
[NCBI]
|
0.000941893
|
|
|
PHEX
|
[NCBI]
|
0.00093298
|
|
|
NR0B1
|
[NCBI]
|
0.000919589
|
|
|
autoimmune thyroid disease, susceptibility to, 1
|
[NCBI]
|
0.00091271
|
|
|
SSX1
|
[NCBI]
|
0.000905801
|
|
|
RENS1
|
[NCBI]
|
0.000903092
|
|
|
POF1
|
[NCBI]
|
0.000890492
|
|
|
LISX1
|
[NCBI]
|
0.000873335
|
|
|
amme complex
|
[NCBI]
|
0.000860381
|
|
|
lujan-fryns syndrome
|
[NCBI]
|
0.000860381
|
|
|
OA1
|
[NCBI]
|
0.000847998
|
|
|
PLP1
|
[NCBI]
|
0.000846817
|
|
|
APC
|
[NCBI]
|
0.000838889
|
|
|
MRX21
|
[NCBI]
|
0.0008313
|
|
|
RP15
|
[NCBI]
|
0.0008313
|
|
|
POF2A
|
[NCBI]
|
0.0008313
|
|
|
hypogammaglobulinemia and isolated growth hormone deficiency, x-linked
|
[NCBI]
|
0.0008313
|
|
|
DKC
|
[NCBI]
|
0.000817529
|
|
|
EMD
|
[NCBI]
|
0.00081381
|
|
|
diabetes insipidus, nephrogenic, x-linked
|
[NCBI]
|
0.000808104
|
|
|
THC1
|
[NCBI]
|
0.00080335
|
|
|
OCRL
|
[NCBI]
|
0.000799817
|
|
|
HBFQTL2
|
[NCBI]
|
0.000796549
|
|
|
MECP2
|
[NCBI]
|
0.000790636
|
|
|
AVPR2
|
[NCBI]
|
0.000787366
|
|
|
MDD
|
[NCBI]
|
0.000764238
|
|
|
persistent hyperplastic primary vitreous, autosomal dominant
|
[NCBI]
|
0.000762204
|
|
|
deafness, high-frequency sensorineural, x-linked
|
[NCBI]
|
0.000762204
|
|
|
MRSD
|
[NCBI]
|
0.000762204
|
|
|
SLI2
|
[NCBI]
|
0.000762204
|
|
|
SLI1
|
[NCBI]
|
0.000762204
|
|
|
MNG2
|
[NCBI]
|
0.000762204
|
|
|
AMELX
|
[NCBI]
|
0.000750784
|
|
|
microcephaly, autosomal dominant
|
[NCBI]
|
0.0007441941
|
|
|
hemophilia a
|
[NCBI]
|
0.000734514
|
|
|
PD
|
[NCBI]
|
0.000715106
|
|
|
TSIX
|
[NCBI]
|
0.00071215
|
|
|
glycogen storage disease ixa
|
[NCBI]
|
0.000709321
|
|
|
OPD2
|
[NCBI]
|
0.000705838
|
|
|
CSNB2A
|
[NCBI]
|
0.000705826
|
|
|
CHM
|
[NCBI]
|
0.000701465
|
|
|
WAS
|
[NCBI]
|
0.00069544
|
|
|
infantile spasm syndrome, x-linked
|
[NCBI]
|
0.000690763
|
|
|
SPG2
|
[NCBI]
|
0.000690763
|
|
|
FDH
|
[NCBI]
|
0.000690458
|
|
|
HTX1
|
[NCBI]
|
0.000689349
|
|
|
GK
|
[NCBI]
|
0.000686454
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
0.000686417
|
|
|
MTM1
|
[NCBI]
|
0.000675732
|
|
|
XRN
|
[NCBI]
|
0.000672937
|
|
|
CND
|
[NCBI]
|
0.000669552
|
|
|
choroideremia with deafness and obesity
|
[NCBI]
|
0.00066499
|
|
|
ASAT
|
[NCBI]
|
0.00066499
|
|
|
dyserythropoietic anemia with thrombocytopenia
|
[NCBI]
|
0.00066499
|
|
|
MRX30
|
[NCBI]
|
0.00066499
|
|
|
MF4
|
[NCBI]
|
0.000655103
|
|
|
pyruvate decarboxylase deficiency
|
[NCBI]
|
0.000641911
|
|
|
CMD3B
|
[NCBI]
|
0.000635193
|
|
|
SRY
|
[NCBI]
|
0.000633491
|
|
|
CD40LG
|
[NCBI]
|
0.000631613
|
|
|
CYBB
|
[NCBI]
|
0.000626468
|
|
|
SHOX
|
[NCBI]
|
0.000623038
|
|
|
MNS
|
[NCBI]
|
0.000575874
|
|
|
xx male syndrome
|
[NCBI]
|
0.000562819
|
|
|
OPA2
|
[NCBI]
|
0.000562451
|
|
|
IL2RG
|
[NCBI]
|
0.00056188
|
|
|
amelogenesis imperfecta, hypoplastic/hypomaturation, x-linked 1
|
[NCBI]
|
0.000559273
|
|
|
opitz syndrome
|
[NCBI]
|
0.000555971
|
|
|
SH2D1A
|
[NCBI]
|
0.000554844
|
|
|
dent disease 1
|
[NCBI]
|
0.000553442
|
|
|
LISX2
|
[NCBI]
|
0.000545577
|
|
|
UBE1
|
[NCBI]
|
0.000542949
|
|
|
MTS
|
[NCBI]
|
0.000537843
|
|
|
POU3F4
|
[NCBI]
|
0.000532885
|
|
|
NYS1
|
[NCBI]
|
0.000524199
|
|
|
TFE3
|
[NCBI]
|
0.000523326
|
|
|
TAZ
|
[NCBI]
|
0.000521777
|
|
|
FRAXE
|
[NCBI]
|
0.000520408
|
|
|
AR
|
[NCBI]
|
0.000517689
|
|
|
MAOA
|
[NCBI]
|
0.000508765
|
|
|
ornithine transcarbamylase deficiency, hyperammonemia due to
|
[NCBI]
|
0.000507227
|
|
|
FPLD1
|
[NCBI]
|
0.000504896
|
|
|
DFNB15
|
[NCBI]
|
0.000504896
|
|
|
hematopoietic stem cell kinetics, control of
|
[NCBI]
|
0.000504054
|
|
|
HMI
|
[NCBI]
|
0.000502306
|
|
|
RPS4X
|
[NCBI]
|
0.000500705
|
|
|
MRX46
|
[NCBI]
|
0.000498705
|
|
|
myotubular myopathy with abnormal genital development
|
[NCBI]
|
0.000498705
|
|
|
atkin-flaitz syndrome
|
[NCBI]
|
0.000498705
|
|
|
brunner syndrome
|
[NCBI]
|
0.000498705
|
|
|
MRX58
|
[NCBI]
|
0.000498705
|
|
|
tetra-amelia, x-linked
|
[NCBI]
|
0.000498705
|
|
|
persistent hyperplastic primary vitreous, autosomal recessive
|
[NCBI]
|
0.000496507
|
|
|
FMR1
|
[NCBI]
|
0.000493309
|
|
|
alport syndrome, autosomal dominant
|
[NCBI]
|
0.000492902
|
|
|
ectodermal dysplasia, hypohidrotic, with immune deficiency
|
[NCBI]
|
0.000483477
|
|
|
clark-baraitser syndrome
|
[NCBI]
|
0.000483477
|
|
|
CLCN4
|
[NCBI]
|
0.000482929
|
|
|
XK
|
[NCBI]
|
0.000475604
|
|
|
graves disease, susceptibility to, 2
|
[NCBI]
|
0.000464011
|
|
|
spondyloepiphyseal dysplasia tarda, autosomal dominant
|
[NCBI]
|
0.000464011
|
|
|
PFC
|
[NCBI]
|
0.000455137
|
|
|
OPD1
|
[NCBI]
|
0.000453709
|
|
|
CD99
|
[NCBI]
|
0.000453194
|
|
|
HEMB
|
[NCBI]
|
0.000453049
|
|
|
TRAPPC2
|
[NCBI]
|
0.000451907
|
|
|
OFD9
|
[NCBI]
|
0.00045011
|
|
|
ODG2
|
[NCBI]
|
0.00044996
|
|
|
PGK1
|
[NCBI]
|
0.000449935
|
|
|
TBG
|
[NCBI]
|
0.000440745
|
|
|
stature quantitative trait locus 6
|
[NCBI]
|
0.000438952
|
|
|
hypertension, essential, susceptibility to, 1
|
[NCBI]
|
0.000438952
|
|
|
PARK11
|
[NCBI]
|
0.000438952
|
|
|
parkinson disease 12
|
[NCBI]
|
0.000438952
|
|
|
COL4A5
|
[NCBI]
|
0.000438902
|
|
|
TAF1
|
[NCBI]
|
0.00042549
|
|
|
ACHE
|
[NCBI]
|
0.000419147
|
|
|
CBD
|
[NCBI]
|
0.000411282
|
|
|
OTC
|
[NCBI]
|
0.000408491
|
|
|
hermaphroditism, true
|
[NCBI]
|
0.000403197
|
|
|
MRX9
|
[NCBI]
|
0.000403197
|
|
|
PCD
|
[NCBI]
|
0.000402838
|
|
|
hydrocephalus
|
[NCBI]
|
0.00040112
|
|
|
TH
|
[NCBI]
|
0.000399968
|
|
|
ZFX
|
[NCBI]
|
0.000398567
|
|
|
ETM2
|
[NCBI]
|
0.000398067
|
|
|
IKBKG
|
[NCBI]
|
0.000393199
|
|
|
leigh syndrome, x-linked
|
[NCBI]
|
0.000391515
|
|
|
PRD
|
[NCBI]
|
0.000391515
|
|
|
FRAXF
|
[NCBI]
|
0.000391515
|
|
|
GFAP
|
[NCBI]
|
0.000388468
|
|
|
EVR2
|
[NCBI]
|
0.000386206
|
|
|
heterotopia, periventricular, x-linked dominant
|
[NCBI]
|
0.000385525
|
|
|
ARX
|
[NCBI]
|
0.000382998
|
|
|
XG
|
[NCBI]
|
0.000380197
|
|
|
spondyloepimetaphyseal dysplasia with multiple dislocations
|
[NCBI]
|
0.000367
|
|
|
EGFR
|
[NCBI]
|
0.00036385
|
|
|
EBP
|
[NCBI]
|
0.000363364
|
|
|
ovary-, testis-, and epididymis-expressed gene
|
[NCBI]
|
0.000362162
|
|
|
ABCB7
|
[NCBI]
|
0.000362162
|
|
|
ARSE
|
[NCBI]
|
0.000360116
|
|
|
FLNA
|
[NCBI]
|
0.000359819
|
|
|
OSCS
|
[NCBI]
|
0.000357671
|
|
|
coronary heart disease, susceptibility to, 2
|
[NCBI]
|
0.00035167
|
|
|
DCX
|
[NCBI]
|
0.000349335
|
|
|
SRS
|
[NCBI]
|
0.00034832
|
|
|
phosphoribosylpyrophosphate synthetase superactivity
|
[NCBI]
|
0.000346144
|
|
|
RENBP
|
[NCBI]
|
0.000345137
|
|
|
SHFM2
|
[NCBI]
|
0.000342421
|
|
|
TIMP1
|
[NCBI]
|
0.000342403
|
|
|
GATA1
|
[NCBI]
|
0.000341932
|
|
|
MRX54
|
[NCBI]
|
0.000339154
|
|
|
RPS6KA3
|
[NCBI]
|
0.000336248
|
|
|
hashimoto thyroiditis
|
[NCBI]
|
0.000333919
|
|
|
GDI1
|
[NCBI]
|
0.000332514
|
|
|
spinocerebellar ataxia, x-linked 3
|
[NCBI]
|
0.000332446
|
|
|
pallister w syndrome
|
[NCBI]
|
0.000332446
|
|
|
radiation sensitivity of natural killer activity
|
[NCBI]
|
0.000332446
|
|
|
OASD
|
[NCBI]
|
0.000332446
|
|
|
DHS
|
[NCBI]
|
0.000332446
|
|
|
radial aplasia, x-linked
|
[NCBI]
|
0.000332446
|
|
|
body length, mouse, human homolog
|
[NCBI]
|
0.000332446
|
|
|
epilepsy, myoclonic, x-linked, with mental retardation and spasticity
|
[NCBI]
|
0.000332446
|
|
|
S PEAK SYNDROME
|
[NCBI]
|
0.000332446
|
|
|
SLC6A8
|
[NCBI]
|
0.000329426
|
|
|
HMS1
|
[NCBI]
|
0.000326753
|
|
|
AMELY
|
[NCBI]
|
0.000324542
|
|
|
pierre robin sequence with pectus excavatum and rib and scapular anomalies
|
[NCBI]
|
0.000320603
|
|
|
MID1
|
[NCBI]
|
0.000317883
|
|
|
OFD1
|
[NCBI]
|
0.000315696
|
|
|
GPC3
|
[NCBI]
|
0.000315102
|
|
|
BGN
|
[NCBI]
|
0.000313623
|
|
|
cutis laxa, x-linked
|
[NCBI]
|
0.000313617
|
|
|
PCNA
|
[NCBI]
|
0.000311793
|
|
|
SOX3
|
[NCBI]
|
0.000311194
|
|
|
AIS
|
[NCBI]
|
0.000311052
|
|
|
homeobox protein, pepp subfamily, 2
|
[NCBI]
|
0.000301787
|
|
|
fabry disease
|
[NCBI]
|
0.000297477
|
|
|
CACNA1F
|
[NCBI]
|
0.000297184
|
|
|
NYS2
|
[NCBI]
|
0.000296024
|
|
|
SRA2
|
[NCBI]
|
0.000295865
|
|
|
pterygium syndrome, multiple, x-linked
|
[NCBI]
|
0.000294722
|
|
|
SS18
|
[NCBI]
|
0.000287228
|
|
|
CBP
|
[NCBI]
|
0.000284669
|
|
|
PHKA1
|
[NCBI]
|
0.000281324
|
|
|
ZIC3
|
[NCBI]
|
0.000280766
|
|
|
proteinuria, low molecular weight, with hypercalciuria and nephrocalcinosis
|
[NCBI]
|
0.000280717
|
|
|
vacterl association with hydrocephalus, x-linked
|
[NCBI]
|
0.000280717
|
|
|
creatine deficiency syndrome, x-linked
|
[NCBI]
|
0.000280717
|
|
|
PTH
|
[NCBI]
|
0.000279419
|
|
|
XS
|
[NCBI]
|
0.0002779636
|
|
|
simpson-golabi-behmel syndrome, type 2
|
[NCBI]
|
0.0002779636
|
|
|
MAFD1
|
[NCBI]
|
0.0002777973
|
|
|
CLCN5
|
[NCBI]
|
0.000277356
|
|
|
KLK3
|
[NCBI]
|
0.0002731402
|
|
|
DYT2
|
[NCBI]
|
0.0002704361
|
|
|
MIC2Y
|
[NCBI]
|
0.000266369
|
|
|
mental health wellness 1
|
[NCBI]
|
0.00026114
|
|
|
JARID1C
|
[NCBI]
|
0.000258822
|
|
|
corpus callosum, agenesis of, with facial anomalies and robin sequence
|
[NCBI]
|
0.000258444
|
|
|
microcephaly, hiatus hernia, and nephrotic syndrome
|
[NCBI]
|
0.000258444
|
|
|
encephalopathy, neonatal severe, due to mecp2 mutations
|
[NCBI]
|
0.0002536864
|
|
|
XCE
|
[NCBI]
|
0.00024698
|
|
|
NSDHL
|
[NCBI]
|
0.00024698
|
|
|
PCDH11X
|
[NCBI]
|
0.00024698
|
|
|
MCF2
|
[NCBI]
|
0.000246296
|
|
|
PAK3
|
[NCBI]
|
0.000245108
|
|
|
LGMD2C
|
[NCBI]
|
0.000243102
|
|
|
CIDX
|
[NCBI]
|
0.000241691
|
|
|
ARTS
|
[NCBI]
|
0.000241691
|
|
|
ubiquitin-activating enzyme, y-linked
|
[NCBI]
|
0.000241691
|
|
|
MRX63
|
[NCBI]
|
0.000241691
|
|
|
gonadal dysgenesis, 46,xy, partial, with minifascicular neuropathy
|
[NCBI]
|
0.000241691
|
|
|
CMD3A
|
[NCBI]
|
0.000241691
|
|
|
thrombocytopenia, platelet dysfunction, hemolysis, and imbalanced globin synthesis
|
[NCBI]
|
0.000241691
|
|
|
MRGH
|
[NCBI]
|
0.000241691
|
|
|
PRPS1
|
[NCBI]
|
0.000241662
|
|
|
MAFD6
|
[NCBI]
|
0.0002404475
|
|
|
GDXY
|
[NCBI]
|
0.000238075
|
|
|
TBC1D25
|
[NCBI]
|
0.0002265871
|
|
|
ESX1L
|
[NCBI]
|
0.0002265871
|
|
|
SSX4
|
[NCBI]
|
0.0002265871
|
|
|
PQBP1
|
[NCBI]
|
0.0002261846
|
|
|
PRTS
|
[NCBI]
|
0.0002249326
|
|
|
CORDX3
|
[NCBI]
|
0.0002249326
|
|
|
CXORF5
|
[NCBI]
|
0.0002236794
|
|
|
congenital hemidysplasia with ichthyosiform erythroderma and limb defects
|
[NCBI]
|
0.000221288
|
|
|
CHAT
|
[NCBI]
|
0.0002173803
|
|
|
HGF
|
[NCBI]
|
0.0002171021
|
|
|
prostate cancer, hereditary, 8
|
[NCBI]
|
0.0002138985
|
|
|
hypophosphatemic rickets, x-linked recessive
|
[NCBI]
|
0.0002135955
|
|
|
HFM
|
[NCBI]
|
0.0002126423
|
|
|
gonadal dysgenesis, xy type
|
[NCBI]
|
0.0002108131
|
|
|
MCOPS2
|
[NCBI]
|
0.0002070777
|
|
|
DKC1
|
[NCBI]
|
0.0002059448
|
|
|
CSF2RA
|
[NCBI]
|
0.0002029211
|
|
|
HOMG
|
[NCBI]
|
0.0002027294
|
|
|
LVNCX
|
[NCBI]
|
0.0002025961
|
|
|
CVID
|
[NCBI]
|
0.0002021037
|
|
|
corpus callosum, partial agenesis of, x-linked
|
[NCBI]
|
0.0002015526
|
|
|
HCFC1
|
[NCBI]
|
0.0002008669
|
|
|
TIMM8A
|
[NCBI]
|
0.0001995774
|
|
|
EDA
|
[NCBI]
|
0.0001969393
|
|
|
PRCC
|
[NCBI]
|
0.0001952026
|
|
|
DIAPH2
|
[NCBI]
|
0.0001952026
|
|
|
autism
|
[NCBI]
|
0.0001949798
|
|
|
TS
|
[NCBI]
|
0.0001908092
|
|
|
GLRA2
|
[NCBI]
|
0.000190707
|
|
|
retinitis pigmentosa, x-linked, with recurrent respiratory infections
|
[NCBI]
|
0.0001902155
|
|
|
muscle glycogenosis, x-linked
|
[NCBI]
|
0.0001902155
|
|
|
PRPS2
|
[NCBI]
|
0.0001857976
|
|
|
AVP
|
[NCBI]
|
0.0001857414
|
|
|
GLUD2
|
[NCBI]
|
0.0001846193
|
|
|
AGTR2
|
[NCBI]
|
0.0001837926
|
|
|
leber optic atrophy
|
[NCBI]
|
0.0001833364
|
|
|
PRKY
|
[NCBI]
|
0.0001810545
|
|
|
IDH3G
|
[NCBI]
|
0.0001810545
|
|
|
XLRL
|
[NCBI]
|
0.0001810545
|
|
|
ASMTL
|
[NCBI]
|
0.0001810545
|
|
|
FEB1
|
[NCBI]
|
0.0001806561
|
|
|
PCDH11Y
|
[NCBI]
|
0.000178955
|
|
|
ELK1
|
[NCBI]
|
0.000178955
|
|
|
APOE
|
[NCBI]
|
0.000176583
|
|
|
ODG1
|
[NCBI]
|
0.0001745006
|
|
|
mental retardation, x-linked, with cerebellar hypoplasia and distinctive facial appearance
|
[NCBI]
|
0.0001745006
|
|
|
hydroxyacyl-coa dehydrogenase ii deficiency
|
[NCBI]
|
0.0001745006
|
|
|
monosomy 9p syndrome
|
[NCBI]
|
0.0001745006
|
|
|
TM4SF2
|
[NCBI]
|
0.0001744594
|
|
|
HTC1
|
[NCBI]
|
0.0001742083
|
|
|
catel-manzke syndrome
|
[NCBI]
|
0.000173693
|
|
|
FSHMD1A
|
[NCBI]
|
0.000169634
|
|
|
POLA
|
[NCBI]
|
0.0001677269
|
|
|
NPPA
|
[NCBI]
|
0.0001669123
|
|
|
EDVX
|
[NCBI]
|
0.0001662104
|
|
|
XLN
|
[NCBI]
|
0.0001662104
|
|
|
neuroendocrine carcinoma of salivary glands, sensorineural hearing loss, and enamel hypoplasia
|
[NCBI]
|
0.0001662104
|
|
|
glycerol kinase, testicular, type b
|
[NCBI]
|
0.0001662104
|
|
|
mycobacterium tuberculosis, susceptibility to, x-linked
|
[NCBI]
|
0.0001662104
|
|
|
charcot-marie-tooth peroneal muscular atrophy, x-linked, with aplasia cutis congenita
|
[NCBI]
|
0.0001662104
|
|
|
dyggve-melchior-clausen syndrome, x-linked
|
[NCBI]
|
0.0001662104
|
|
|
fragile site 9q32
|
[NCBI]
|
0.0001662104
|
|
|
brachydactyly, mononen type
|
[NCBI]
|
0.0001662104
|
|
|
pierre robin sequence with facial and digital anomalies
|
[NCBI]
|
0.0001662104
|
|
|
contiguous abcd1/dxs1375e deletion syndrome
|
[NCBI]
|
0.0001662104
|
|
|
calvarial hyperostosis
|
[NCBI]
|
0.0001662104
|
|
|
opticoacoustic nerve atrophy with dementia
|
[NCBI]
|
0.0001662104
|
|
|
B1G2
|
[NCBI]
|
0.0001662104
|
|
|
spinocerebellar ataxia, x-linked 4
|
[NCBI]
|
0.0001662104
|
|
|
hypersecretion of adrenal androgens, familial
|
[NCBI]
|
0.0001662104
|
|
|
mental retardation associated with psoriasis
|
[NCBI]
|
0.0001662104
|
|
|
leukemia, acute, ?x-linked
|
[NCBI]
|
0.0001662104
|
|
|
microcephaly with digital anomalies
|
[NCBI]
|
0.0001662104
|
|
|
muscular dystrophy, progressive pectorodorsal
|
[NCBI]
|
0.0001662104
|
|
|
AMCBX1
|
[NCBI]
|
0.0001662104
|
|
|
mental retardation, x-linked, with craniofacial dysmorphism
|
[NCBI]
|
0.0001662104
|
|
|
arthrogryposis, ectodermal dysplasia, cleft lip/palate, and developmental delay
|
[NCBI]
|
0.0001662104
|
|
|
hemopoietic proliferation
|
[NCBI]
|
0.0001662104
|
|
|
imprinting gene related to retinoblastoma
|
[NCBI]
|
0.0001662104
|
|
|
gonadal dysgenesis, hypergonadotropic, xx type, short stature, and recurrent metabolic acidosis
|
[NCBI]
|
0.0001662104
|
|
|
glycerol kinase, testicular, type a
|
[NCBI]
|
0.0001662104
|
|
|
neuropathy, hereditary sensory, x-linked
|
[NCBI]
|
0.0001662104
|
|
|
male infertility from defect in meiosis
|
[NCBI]
|
0.0001662104
|
|
|
cervical ribs, sprengel anomaly, anal atresia, and urethral obstruction
|
[NCBI]
|
0.0001662104
|
|
|
lymphedema-hypoparathyroidism syndrome
|
[NCBI]
|
0.0001662104
|
|
|
uruguay faciocardiomusculoskeletal syndrome
|
[NCBI]
|
0.0001662104
|
|
|
TAQ1
|
[NCBI]
|
0.0001662104
|
|
|
schimke x-linked mental retardation syndrome
|
[NCBI]
|
0.0001662104
|
|
|
spondyloepimetaphyseal dysplasia, x-linked, with mental deterioration
|
[NCBI]
|
0.0001662104
|
|
|
OLEDAID
|
[NCBI]
|
0.0001662104
|
|
|
nRNA
|
[NCBI]
|
0.0001662104
|
|
|
frontonasal dysplasia
|
[NCBI]
|
0.0001662104
|
|
|
ulnar hypoplasia with lobster-claw deformity of feet
|
[NCBI]
|
0.0001662104
|
|
|
alopecia, congenital
|
[NCBI]
|
0.0001662104
|
|
|
cone dystrophy, x-linked, with tapetal-like sheen
|
[NCBI]
|
0.0001662104
|
|
|
radioulnar synostosis, radial ray abnormalities, and severe malformations in the male
|
[NCBI]
|
0.0001662104
|
|
|
spastic paraparesis and deafness
|
[NCBI]
|
0.0001662104
|
|
|
MRX14
|
[NCBI]
|
0.0001662104
|
|
|
facial dysmorphism, cleft palate, hearing loss, and camptodactyly
|
[NCBI]
|
0.0001662104
|
|
|
russell-silver syndrome, x-linked
|
[NCBI]
|
0.0001662104
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-negative
|
[NCBI]
|
0.0001659373
|
|
|
LAMP2
|
[NCBI]
|
0.0001634323
|
|
|
OPHN1
|
[NCBI]
|
0.0001607828
|
|
|
ARHGEF6
|
[NCBI]
|
0.0001607828
|
|
|
GRPR
|
[NCBI]
|
0.0001606578
|
|
|
periodontitis, aggressive, 1
|
[NCBI]
|
0.0001591905
|
|
|
GCY
|
[NCBI]
|
0.0001576897
|
|
|
spinocerebellar ataxia 29
|
[NCBI]
|
0.0001576897
|
|
|
MRXSL
|
[NCBI]
|
0.0001541453
|
|
|
HCCS
|
[NCBI]
|
0.000151608
|
|
|
RPS4Y
|
[NCBI]
|
0.000151608
|
|
|
ATP6AP1
|
[NCBI]
|
0.000151608
|
|
|
ASPSCR1
|
[NCBI]
|
0.000151608
|
|
|
MAGEB2
|
[NCBI]
|
0.000151608
|
|
|
ZNF81
|
[NCBI]
|
0.000151608
|
|
|
FACL4
|
[NCBI]
|
0.0001509158
|
|
|
OCRL
|
[NCBI]
|
0.0001500457
|
|
|
HPRT1
|
[NCBI]
|
0.0001492158
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type i
|
[NCBI]
|
0.0001489393
|
|
|
FGD1
|
[NCBI]
|
0.0001475378
|
|
|
palmoplantar hyperkeratosis with squamous cell carcinoma of skin and sex reversal
|
[NCBI]
|
0.0001472894
|
|
|
intestinal pseudoobstruction, neuronal, chronic idiopathic, x-linked
|
[NCBI]
|
0.000144768
|
|
|
BWS
|
[NCBI]
|
0.0001422578
|
|
|
wildervanck syndrome
|
[NCBI]
|
0.000139057
|
|
|
spondyloepimetaphyseal dysplasia, x-linked
|
[NCBI]
|
0.0001389696
|
|
|
leg ulcers, familial, of juvenile onset
|
[NCBI]
|
0.0001389696
|
|
|
XMRE
|
[NCBI]
|
0.0001389696
|
|
|
sjogren-larsson-like ichthyosis without cns or eye involvement
|
[NCBI]
|
0.0001389696
|
|
|
obesity, susceptibility to, x-linked
|
[NCBI]
|
0.0001389696
|
|
|
MRXS10
|
[NCBI]
|
0.0001389696
|
|
|
myoclonic epilepsy, progressive
|
[NCBI]
|
0.0001389696
|
|
|
DSS
|
[NCBI]
|
0.0001379121
|
|
|
CDR1
|
[NCBI]
|
0.0001370699
|
|
|
MAGEB1
|
[NCBI]
|
0.0001370699
|
|
|
CCT
|
[NCBI]
|
0.0001370699
|
|
|
PFKFB1
|
[NCBI]
|
0.0001370699
|
|
|
GABRA3
|
[NCBI]
|
0.0001370699
|
|
|
VCX3A
|
[NCBI]
|
0.0001370699
|
|
|
SLC25A6
|
[NCBI]
|
0.0001370699
|
|
|
leiomyomatosis, esophageal and vulval, with nephropathy
|
[NCBI]
|
0.0001370342
|
|
|
EDMD2
|
[NCBI]
|
0.0001359355
|
|
|
IGAD1
|
[NCBI]
|
0.0001346025
|
|
|
FOXP3
|
[NCBI]
|
0.0001315344
|
|
|
JARID1D
|
[NCBI]
|
0.0001314783
|
|
|
AS
|
[NCBI]
|
0.0001307292
|
|
|
PWS
|
[NCBI]
|
0.0001303347
|
|
|
retinitis pigmentosa, late-adult onset
|
[NCBI]
|
0.0001290197
|
|
|
muscular dystrophy, hemizygous lethal type
|
[NCBI]
|
0.0001290197
|
|
|
NHS
|
[NCBI]
|
0.0001287591
|
|
|
ARAF1
|
[NCBI]
|
0.0001287591
|
|
|
MBP
|
[NCBI]
|
0.0001285291
|
|
|
hypogonadism, male
|
[NCBI]
|
0.0001280053
|
|
|
testes, rudimentary
|
[NCBI]
|
0.0001280053
|
|
|
NSX
|
[NCBI]
|
0.0001280053
|
|
|
scott craniodigital syndrome with mental retardation
|
[NCBI]
|
0.0001280053
|
|
|
ADHR
|
[NCBI]
|
0.0001273684
|
|
|
PGK2
|
[NCBI]
|
0.0001267804
|
|
|
MTMR1
|
[NCBI]
|
0.0001267651
|
|
|
IGSF1
|
[NCBI]
|
0.0001267651
|
|
|
SMS
|
[NCBI]
|
0.0001267651
|
|
|
DWS
|
[NCBI]
|
0.0001267518
|
|
|
AFP
|
[NCBI]
|
0.0001244616
|
|
|
MPP1
|
[NCBI]
|
0.0001231224
|
|
|
TBX22
|
[NCBI]
|
0.0001231224
|
|
|
HAE III
|
[NCBI]
|
0.0001227451
|
|
|
GLA
|
[NCBI]
|
0.0001220898
|
|
|
HNRPH2
|
[NCBI]
|
0.0001206971
|
|
|
NUDT11
|
[NCBI]
|
0.0001206971
|
|
|
SSX3
|
[NCBI]
|
0.0001206971
|
|
|
ARSF
|
[NCBI]
|
0.0001206971
|
|
|
pseudoautosomal gene xe7
|
[NCBI]
|
0.0001206971
|
|
|
SMPX
|
[NCBI]
|
0.0001206971
|
|
|
MRX49
|
[NCBI]
|
0.0001206971
|
|
|
USP11
|
[NCBI]
|
0.0001206971
|
|
|
FAM50A
|
[NCBI]
|
0.0001206971
|
|
|
BRS3
|
[NCBI]
|
0.0001206971
|
|
|
dxf34 gene
|
[NCBI]
|
0.0001206971
|
|
|
CLIC2
|
[NCBI]
|
0.0001206971
|
|
|
SRPX
|
[NCBI]
|
0.0001206971
|
|
|
IL1RAPL2
|
[NCBI]
|
0.0001206971
|
|
|
UBL4A
|
[NCBI]
|
0.0001206971
|
|
|
KCNE1L
|
[NCBI]
|
0.0001206971
|
|
|
NUDT10
|
[NCBI]
|
0.0001206971
|
|
|
XE7Y
|
[NCBI]
|
0.0001206971
|
|
|
DNASE1L1
|
[NCBI]
|
0.0001206971
|
|
|
VCY
|
[NCBI]
|
0.0001206971
|
|
|
CFTR
|
[NCBI]
|
0.0001199768
|
|
|
RBMX
|
[NCBI]
|
0.0001187269
|
|
|
IL1RAPL1
|
[NCBI]
|
0.0001187269
|
|
|
RPL10
|
[NCBI]
|
0.0001157346
|
|
|
MLLT7
|
[NCBI]
|
0.0001157346
|
|
|
barber-say syndrome
|
[NCBI]
|
0.0001142526
|
|
|
hydrocephalus with cerebellar agenesis
|
[NCBI]
|
0.0001142526
|
|
|
taurodontism
|
[NCBI]
|
0.0001142526
|
|
|
HIST1H3C
|
[NCBI]
|
0.0001131946
|
|
|
COL4A6
|
[NCBI]
|
0.0001121264
|
|
|
IL9R
|
[NCBI]
|
0.0001109884
|
|
|
SYP
|
[NCBI]
|
0.0001100136
|
|
|
deafness, autosomal recessive
|
[NCBI]
|
0.000109555
|
|
|
ARHGAP4
|
[NCBI]
|
0.0001093911
|
|
|
midline 2
|
[NCBI]
|
0.0001093911
|
|
|
GPM6B
|
[NCBI]
|
0.0001093911
|
|
|
tritanopia
|
[NCBI]
|
0.0001072938
|
|
|
LWD
|
[NCBI]
|
0.000106244
|
|
|
membranoproliferative glomerulonephritis, x-linked
|
[NCBI]
|
0.0001056975
|
|
|
SYN1
|
[NCBI]
|
0.0001043196
|
|
|
TMSB4X
|
[NCBI]
|
0.0001043196
|
|
|
ZNF185
|
[NCBI]
|
0.0001043112
|
|
|
CD244
|
[NCBI]
|
0.0001038692
|
|
|
diabetes insipidus, nephrogenic, autosomal
|
[NCBI]
|
0.0001027802
|
|
|
mental retardation, x-linked, with short stature, small testes, muscle wasting, and tremor
|
[NCBI]
|
0.0001007645
|
|
|
coxoauricular syndrome
|
[NCBI]
|
0.0001007645
|
|
|
acrofacial dysostosis, catania type
|
[NCBI]
|
0.0001007645
|
|
|
tyrosine aminotransferase, regulator of
|
[NCBI]
|
0.0001007645
|
|
|
MCOPCT3
|
[NCBI]
|
0.0001007645
|
|
|
paine syndrome
|
[NCBI]
|
0.0001007645
|
|
|
MRXS14
|
[NCBI]
|
0.0001007645
|
|
|
wiskott-aldrich syndrome
|
[NCBI]
|
0.0001007645
|
|
|
testicular torsion
|
[NCBI]
|
0.0001007645
|
|
|
stocco dos santos x-linked mental retardation syndrome
|
[NCBI]
|
0.0001007645
|
|
|
corpus callosum, agenesis of, with abnormal genitalia
|
[NCBI]
|
0.0001007645
|
|
|
MRX45
|
[NCBI]
|
0.0001007645
|
|
|
holoprosencephaly with fetal akinesia/hypokinesia sequence
|
[NCBI]
|
0.0001007645
|
|
|
mental retardation, x-linked, with brachydactyly and macroglossia
|
[NCBI]
|
0.0001007645
|
|
|
MRX93
|
[NCBI]
|
0.0001007645
|
|
|
mcdonough syndrome
|
[NCBI]
|
0.0001007645
|
|
|
prader-willi habitus, osteopenia, and camptodactyly
|
[NCBI]
|
0.0001007645
|
|
|
epileptic encephalopathy, lennox-gastaut type
|
[NCBI]
|
0.0001007645
|
|
|
multiple pterygium syndrome, lethal type
|
[NCBI]
|
9.89209e-05
|
|
|
BL
|
[NCBI]
|
9.65253e-05
|
|
|
ZNF21
|
[NCBI]
|
9.57194e-05
|
|
|
SHROOM2
|
[NCBI]
|
9.57194e-05
|
|
|
ARSD
|
[NCBI]
|
9.57194e-05
|
|
|
SPANXA1
|
[NCBI]
|
9.57194e-05
|
|
|
MAGED2
|
[NCBI]
|
9.57194e-05
|
|
|
CETN2
|
[NCBI]
|
9.57194e-05
|
|
|
PRKX
|
[NCBI]
|
9.57194e-05
|
|
|
DDX3
|
[NCBI]
|
9.57194e-05
|
|
|
AMD1
|
[NCBI]
|
9.57194e-05
|
|
|
CFNS
|
[NCBI]
|
9.29453e-05
|
|
|
MED12
|
[NCBI]
|
9.26022e-05
|
|
|
ZFY
|
[NCBI]
|
9.19449e-05
|
|
|
dyskeratosis congenita, autosomal recessive
|
[NCBI]
|
9.08146e-05
|
|
|
fetal akinesia syndrome, x-linked
|
[NCBI]
|
9.08146e-05
|
|
|
genitopalatocardiac syndrome
|
[NCBI]
|
9.08146e-05
|
|
|
epstein-barr virus, susceptibility to chronic infection by
|
[NCBI]
|
9.08146e-05
|
|
|
roifman syndrome
|
[NCBI]
|
9.08146e-05
|
|
|
siderius x-linked mental retardation syndrome
|
[NCBI]
|
9.08146e-05
|
|
|
chromosome xp11.3 deletion syndrome
|
[NCBI]
|
9.08146e-05
|
|
|
autism, x-linked, susceptibility to, 2
|
[NCBI]
|
9.08146e-05
|
|
|
hydrocephalus due to congenital stenosis of aqueduct of sylvius
|
[NCBI]
|
9.08146e-05
|
|
|
GPR34
|
[NCBI]
|
9.06395e-05
|
|
|
RHO
|
[NCBI]
|
9.03109e-05
|
|
|
EFNB1
|
[NCBI]
|
8.72809e-05
|
|
|
IL3RA
|
[NCBI]
|
8.71693e-05
|
|
|
alopecia-contractures-dwarfism mental retardation syndrome
|
[NCBI]
|
8.70118e-05
|
|
|
FMD
|
[NCBI]
|
8.66413e-05
|
|
|
urogenital adysplasia, hereditary
|
[NCBI]
|
8.59874e-05
|
|
|
gonadal agenesis
|
[NCBI]
|
8.454e-05
|
|
|
branchial arch syndrome, x-linked
|
[NCBI]
|
8.454e-05
|
|
|
ZNF75
|
[NCBI]
|
8.45043e-05
|
|
|
NAP1L2
|
[NCBI]
|
8.45043e-05
|
|
|
NONO
|
[NCBI]
|
8.45043e-05
|
|
|
MAGEA8
|
[NCBI]
|
8.45043e-05
|
|
|
histone deacetylase 8
|
[NCBI]
|
8.45043e-05
|
|
|
CXORF6
|
[NCBI]
|
8.45043e-05
|
|
|
SYBL1
|
[NCBI]
|
8.45043e-05
|
|
|
PRKCI
|
[NCBI]
|
8.45043e-05
|
|
|
MAGEA5
|
[NCBI]
|
8.45043e-05
|
|
|
HMGB3
|
[NCBI]
|
8.45043e-05
|
|
|
SPANXB1
|
[NCBI]
|
8.45043e-05
|
|
|
PCD
|
[NCBI]
|
8.43808e-05
|
|
|
XPNPEP2
|
[NCBI]
|
8.23834e-05
|
|
|
BEX1
|
[NCBI]
|
8.10341e-05
|
|
|
CALB3
|
[NCBI]
|
8.10341e-05
|
|
|
ATP6AP2
|
[NCBI]
|
8.10341e-05
|
|
|
PCTK1
|
[NCBI]
|
8.10341e-05
|
|
|
CHML
|
[NCBI]
|
8.10341e-05
|
|
|
spinal muscular atrophy, type i, with congenital bone fractures
|
[NCBI]
|
8.0011e-05
|
|
|
PMDS
|
[NCBI]
|
7.9639e-05
|
|
|
SLC16A2
|
[NCBI]
|
7.7695e-05
|
|
|
lathosterolosis
|
[NCBI]
|
7.70619e-05
|
|
|
mental retardation, x-linked, snyder-robinson type
|
[NCBI]
|
7.70619e-05
|
|
|
brachydactyly, preaxial, with hallux varus and thumb abduction
|
[NCBI]
|
7.70619e-05
|
|
|
agonadism with multiple internal malformations
|
[NCBI]
|
7.70619e-05
|
|
|
NYX
|
[NCBI]
|
7.68475e-05
|
|
|
TRO
|
[NCBI]
|
7.68475e-05
|
|
|
FGF13
|
[NCBI]
|
7.68475e-05
|
|
|
GPC4
|
[NCBI]
|
7.68475e-05
|
|
|
BCAP31
|
[NCBI]
|
7.68475e-05
|
|
|
IL7R
|
[NCBI]
|
7.64204e-05
|
|
|
C1QG
|
[NCBI]
|
7.62482e-05
|
|
|
C1QB
|
[NCBI]
|
7.62482e-05
|
|
|
DLG3
|
[NCBI]
|
7.4201e-05
|
|
|
FTSJ1
|
[NCBI]
|
7.4201e-05
|
|
|
ZFPM1
|
[NCBI]
|
7.4201e-05
|
|
|
SOX9
|
[NCBI]
|
7.27875e-05
|
|
|
EKD1
|
[NCBI]
|
7.14526e-05
|
|
|
MAGEA1
|
[NCBI]
|
7.10115e-05
|
|
|
mental retardation, x-linked, syndromic, jarid1c-related
|
[NCBI]
|
7.07873e-05
|
|
|
TS
|
[NCBI]
|
7.07873e-05
|
|
|
RP19
|
[NCBI]
|
7.07873e-05
|
|
|
HPC1
|
[NCBI]
|
7.07344e-05
|
|
|
PRKCB1
|
[NCBI]
|
6.88721e-05
|
|
|
CASK
|
[NCBI]
|
6.84357e-05
|
|
|
CUL4B
|
[NCBI]
|
6.70777e-05
|
|
|
SMC1A
|
[NCBI]
|
6.70777e-05
|
|
|
MAOB
|
[NCBI]
|
6.64526e-05
|
|
|
DBY
|
[NCBI]
|
6.62963e-05
|
|
|
RBMY1A1
|
[NCBI]
|
6.62963e-05
|
|
|
HNRPD
|
[NCBI]
|
6.62963e-05
|
|
|
FANCB
|
[NCBI]
|
6.62963e-05
|
|
|
microcephaly with spastic quadriplegia
|
[NCBI]
|
6.62583e-05
|
|
|
eunuchoidism, familial hypogonadotropic
|
[NCBI]
|
6.62583e-05
|
|
|
von willebrand disease, recessive form
|
[NCBI]
|
6.49105e-05
|
|
|
LAMP1
|
[NCBI]
|
6.45019e-05
|
|
|
C1QA
|
[NCBI]
|
6.2977e-05
|
|
|
FHL1
|
[NCBI]
|
6.29582e-05
|
|
|
thyroxine-binding globulin of serum
|
[NCBI]
|
6.27574e-05
|
|
|
DFNA11
|
[NCBI]
|
6.27574e-05
|
|
|
coats disease
|
[NCBI]
|
6.24203e-05
|
|
|
USP9Y
|
[NCBI]
|
6.23439e-05
|
|
|
TBL1X
|
[NCBI]
|
6.23439e-05
|
|
|
RGN
|
[NCBI]
|
6.23439e-05
|
|
|
ELK3
|
[NCBI]
|
6.23439e-05
|
|
|
immunodeficiency with hyper-igm, type 3
|
[NCBI]
|
6.22322e-05
|
|
|
dna, satellite, alpha type
|
[NCBI]
|
6.22322e-05
|
|
|
microcephaly with chemotactic defect and transient hypogammaglobulinemia
|
[NCBI]
|
6.22322e-05
|
|
|
charcot-marie-tooth disease, axonal, with vocal cord paresis, autosomal recessive
|
[NCBI]
|
6.22322e-05
|
|
|
RP18
|
[NCBI]
|
6.22322e-05
|
|
|
hair whorl
|
[NCBI]
|
6.22322e-05
|
|
|
anal atresia, hypospadias, and penoscrotal inversion
|
[NCBI]
|
6.22322e-05
|
|
|
AIS1
|
[NCBI]
|
6.22322e-05
|
|
|
PTLS
|
[NCBI]
|
6.22322e-05
|
|
|
endocardial fibroelastosis
|
[NCBI]
|
6.22322e-05
|
|
|
CNTF
|
[NCBI]
|
6.09863e-05
|
|
|
CTAG1B
|
[NCBI]
|
6.08002e-05
|
|
|
ZXDA
|
[NCBI]
|
6.03456e-05
|
|
|
SCML2
|
[NCBI]
|
6.03456e-05
|
|
|
H2BFWT
|
[NCBI]
|
6.03456e-05
|
|
|
spindlin family, member 2
|
[NCBI]
|
6.03456e-05
|
|
|
CXORF1
|
[NCBI]
|
6.03456e-05
|
|
|
DYNLT3
|
[NCBI]
|
6.03456e-05
|
|
|
ZNF711
|
[NCBI]
|
6.03456e-05
|
|
|
RNF17
|
[NCBI]
|
6.03456e-05
|
|
|
CSF2RY
|
[NCBI]
|
6.03456e-05
|
|
|
MIC2R
|
[NCBI]
|
6.03456e-05
|
|
|
radial ray deficiency, x-linked
|
[NCBI]
|
6.03456e-05
|
|
|
EEF1B3
|
[NCBI]
|
6.03456e-05
|
|
|
FTHL17
|
[NCBI]
|
6.03456e-05
|
|
|
TEX12
|
[NCBI]
|
6.03456e-05
|
|
|
GAGE8
|
[NCBI]
|
6.03456e-05
|
|
|
HNRPH1
|
[NCBI]
|
6.03456e-05
|
|
|
CHST7
|
[NCBI]
|
6.03456e-05
|
|
|
CXX1
|
[NCBI]
|
6.03456e-05
|
|
|
dxf68s1e
|
[NCBI]
|
6.03456e-05
|
|
|
ZXDB
|
[NCBI]
|
6.03456e-05
|
|
|
CXORF12
|
[NCBI]
|
6.03456e-05
|
|
|
TIMM17B
|
[NCBI]
|
6.03456e-05
|
|
|
PLAC1
|
[NCBI]
|
6.03456e-05
|
|
|
TAF7L
|
[NCBI]
|
6.03456e-05
|
|
|
SPANXN5
|
[NCBI]
|
6.03456e-05
|
|
|
MTCP1
|
[NCBI]
|
6.03456e-05
|
|
|
thrombocytosis, familial x-linked
|
[NCBI]
|
6.03456e-05
|
|
|
PABPC5
|
[NCBI]
|
6.03456e-05
|
|
|
STK31
|
[NCBI]
|
6.03456e-05
|
|
|
ANT3Y
|
[NCBI]
|
6.03456e-05
|
|
|
TEX13A
|
[NCBI]
|
6.03456e-05
|
|
|
SPANXN2
|
[NCBI]
|
6.03456e-05
|
|
|
GPR45
|
[NCBI]
|
6.03456e-05
|
|
|
A11
|
[NCBI]
|
6.03456e-05
|
|
|
VDAC4
|
[NCBI]
|
6.03456e-05
|
|
|
PRRG3
|
[NCBI]
|
6.03456e-05
|
|
|
UBL4B
|
[NCBI]
|
6.03456e-05
|
|
|
RAI2
|
[NCBI]
|
6.03456e-05
|
|
|
DDX43
|
[NCBI]
|
6.03456e-05
|
|
|
ARMCX3
|
[NCBI]
|
6.03456e-05
|
|
|
SPANXN3
|
[NCBI]
|
6.03456e-05
|
|
|
SSX2
|
[NCBI]
|
6.03456e-05
|
|
|
SSX5
|
[NCBI]
|
6.03456e-05
|
|
|
TEX15
|
[NCBI]
|
6.03456e-05
|
|
|
acetylserotonin methyltransferase-like, y-linked
|
[NCBI]
|
6.03456e-05
|
|
|
ARSC2
|
[NCBI]
|
6.03456e-05
|
|
|
MYCL2
|
[NCBI]
|
6.03456e-05
|
|
|
xk-related protein on y chromosome
|
[NCBI]
|
6.03456e-05
|
|
|
INE1
|
[NCBI]
|
6.03456e-05
|
|
|
SPANXN4
|
[NCBI]
|
6.03456e-05
|
|
|
VCX
|
[NCBI]
|
6.03456e-05
|
|
|
SH3BGRL
|
[NCBI]
|
6.03456e-05
|
|
|
EEF1B4
|
[NCBI]
|
6.03456e-05
|
|
|
UTP14A
|
[NCBI]
|
6.03456e-05
|
|
|
ACRC
|
[NCBI]
|
6.03456e-05
|
|
|
CCRL2
|
[NCBI]
|
6.03456e-05
|
|
|
mental retardation, x-linked, with short stature
|
[NCBI]
|
6.03456e-05
|
|
|
RAB9B
|
[NCBI]
|
6.03456e-05
|
|
|
PFKFB2
|
[NCBI]
|
6.03456e-05
|
|
|
heterogeneous nuclear ribonucleoprotein g-t
|
[NCBI]
|
6.03456e-05
|
|
|
SCML1
|
[NCBI]
|
6.03456e-05
|
|
|
SPANXC
|
[NCBI]
|
6.03456e-05
|
|
|
EIF1AY
|
[NCBI]
|
6.03456e-05
|
|
|
PLS1
|
[NCBI]
|
6.03456e-05
|
|
|
GPR20
|
[NCBI]
|
6.03456e-05
|
|
|
ras-like gtpase gene
|
[NCBI]
|
6.03456e-05
|
|
|
MSL3L1
|
[NCBI]
|
6.03456e-05
|
|
|
LMO6
|
[NCBI]
|
6.03456e-05
|
|
|
SSR4
|
[NCBI]
|
6.03456e-05
|
|
|
KLHL4
|
[NCBI]
|
6.03456e-05
|
|
|
GPR21
|
[NCBI]
|
6.03456e-05
|
|
|
IL3RA
|
[NCBI]
|
6.03456e-05
|
|
|
TEX13B
|
[NCBI]
|
6.03456e-05
|
|
|
CRLF2Y
|
[NCBI]
|
6.03456e-05
|
|
|
TEX11
|
[NCBI]
|
6.03456e-05
|
|
|
HSPA9B
|
[NCBI]
|
6.03456e-05
|
|
|
dxs9879e
|
[NCBI]
|
6.03456e-05
|
|
|
ZNF157
|
[NCBI]
|
6.03456e-05
|
|
|
GAGEC1
|
[NCBI]
|
6.03456e-05
|
|
|
H2AFB
|
[NCBI]
|
6.03456e-05
|
|
|
NAP1L3
|
[NCBI]
|
6.03456e-05
|
|
|
utp14, s. cerevisiae, homolog of, b
|
[NCBI]
|
6.03456e-05
|
|
|
PRRG4
|
[NCBI]
|
6.03456e-05
|
|
|
LDOC1
|
[NCBI]
|
6.03456e-05
|
|
|
INE2
|
[NCBI]
|
6.03456e-05
|
|
|
fetal and adult testis-expressed gene
|
[NCBI]
|
6.03456e-05
|
|
|
VCX2
|
[NCBI]
|
6.03456e-05
|
|
|
mental retardation, x-linked, south african type
|
[NCBI]
|
6.03456e-05
|
|
|
SPANXN1
|
[NCBI]
|
6.03456e-05
|
|
|
mov10-like 1
|
[NCBI]
|
6.03456e-05
|
|
|
XGR
|
[NCBI]
|
6.03456e-05
|
|
|
GPR22
|
[NCBI]
|
6.03456e-05
|
|
|
CTAG1A
|
[NCBI]
|
6.03456e-05
|
|
|
ARMCX3
|
[NCBI]
|
6.03456e-05
|
|
|
CTPS2
|
[NCBI]
|
6.03456e-05
|
|
|
ectodermal dysplasia, anhidrotic
|
[NCBI]
|
5.99359e-05
|
|
|
SLC34A1
|
[NCBI]
|
5.89455e-05
|
|
|
ASPS
|
[NCBI]
|
5.8381e-05
|
|
|
DFNA13
|
[NCBI]
|
5.77032e-05
|
|
|
CDHS
|
[NCBI]
|
5.77032e-05
|
|
|
immunodeficiency with hyper-igm, type 2
|
[NCBI]
|
5.61457e-05
|
|
|
ATP7A
|
[NCBI]
|
5.58015e-05
|
|
|
MTHFD1
|
[NCBI]
|
5.52773e-05
|
|
|
PIGA
|
[NCBI]
|
5.50644e-05
|
|
|
STHAG1
|
[NCBI]
|
5.42023e-05
|
|
|
DFNA1
|
[NCBI]
|
5.42023e-05
|
|
|
GRIA3
|
[NCBI]
|
5.33213e-05
|
|
|
HSD17B10
|
[NCBI]
|
5.33213e-05
|
|
|
GMPR
|
[NCBI]
|
5.33213e-05
|
|
|
ZNF674
|
[NCBI]
|
5.21527e-05
|
|
|
ZNF673
|
[NCBI]
|
5.21527e-05
|
|
|
TSPAN6
|
[NCBI]
|
5.21527e-05
|
|
|
ZFP37
|
[NCBI]
|
5.21527e-05
|
|
|
SHOXY
|
[NCBI]
|
5.21527e-05
|
|
|
MRX59
|
[NCBI]
|
5.16167e-05
|
|
|
anemia, microcytic
|
[NCBI]
|
5.16167e-05
|
|
|
vacterl association with hydrocephalus
|
[NCBI]
|
5.13808e-05
|
|
|
TG
|
[NCBI]
|
5.12276e-05
|
|
|
CTCF
|
[NCBI]
|
5.11518e-05
|
|
|
MSN
|
[NCBI]
|
4.99585e-05
|
|
|
MT1A
|
[NCBI]
|
4.95267e-05
|
|
|
BLNK
|
[NCBI]
|
4.87822e-05
|
|
|
ESD
|
[NCBI]
|
4.8545e-05
|
|
|
whim syndrome
|
[NCBI]
|
4.81158e-05
|
|
|
SLC6A14
|
[NCBI]
|
4.71275e-05
|
|
|
hydrops-ectopic calcification-moth-eaten skeletal dysplasia
|
[NCBI]
|
4.70644e-05
|
|
|
GNRH1
|
[NCBI]
|
4.62474e-05
|
|
|
pneumothorax, primary spontaneous
|
[NCBI]
|
4.52943e-05
|
|
|
BIRC4
|
[NCBI]
|
4.37827e-05
|
|
|
DFNB7
|
[NCBI]
|
4.34832e-05
|
|
|
azoospermia due to perturbations of meiosis
|
[NCBI]
|
4.34832e-05
|
|
|
boomerang dysplasia
|
[NCBI]
|
4.34832e-05
|
|
|
peroxisomal acyl-coa oxidase deficiency
|
[NCBI]
|
4.33123e-05
|
|
|
myopathy, centronuclear, autosomal recessive
|
[NCBI]
|
4.33123e-05
|
|
|
dentin dysplasia, type ii
|
[NCBI]
|
4.33123e-05
|
|
|
HEPH
|
[NCBI]
|
4.33068e-05
|
|
|
MJD
|
[NCBI]
|
4.31577e-05
|
|
|
AITD3
|
[NCBI]
|
4.29556e-05
|
|
|
EIF2S3
|
[NCBI]
|
4.22493e-05
|
|
|
DACH2
|
[NCBI]
|
4.22493e-05
|
|
|
GAGE1
|
[NCBI]
|
4.22493e-05
|
|
|
HNRPF
|
[NCBI]
|
4.22493e-05
|
|
|
TIMM17A
|
[NCBI]
|
4.22493e-05
|
|
|
BPY2
|
[NCBI]
|
4.22493e-05
|
|
|
early lymphoid activation gene
|
[NCBI]
|
4.22493e-05
|
|
|
pseudoautosomal gtp-binding protein-like
|
[NCBI]
|
4.22493e-05
|
|
|
PNCK
|
[NCBI]
|
4.22493e-05
|
|
|
USP9X
|
[NCBI]
|
4.22493e-05
|
|
|
CDX4
|
[NCBI]
|
4.22493e-05
|
|
|
MAGEB3
|
[NCBI]
|
4.22493e-05
|
|
|
ZNF261
|
[NCBI]
|
4.22493e-05
|
|
|
CXORF2
|
[NCBI]
|
4.22493e-05
|
|
|
CDY2
|
[NCBI]
|
4.22493e-05
|
|
|
BMX
|
[NCBI]
|
4.22493e-05
|
|
|
TM4SF1
|
[NCBI]
|
4.22493e-05
|
|
|
KIF4B
|
[NCBI]
|
4.22493e-05
|
|
|
GAGE2
|
[NCBI]
|
4.22493e-05
|
|
|
DOCK8
|
[NCBI]
|
4.22493e-05
|
|
|
MAGEB4
|
[NCBI]
|
4.22493e-05
|
|
|
ASMT
|
[NCBI]
|
4.22493e-05
|
|
|
CCNB3
|
[NCBI]
|
4.22493e-05
|
|
|
GPR50
|
[NCBI]
|
4.22493e-05
|
|
|
SPANXA2
|
[NCBI]
|
4.22493e-05
|
|
|
MAGEB6
|
[NCBI]
|
4.22493e-05
|
|
|
MAGEH1
|
[NCBI]
|
4.22493e-05
|
|
|
ZFP161
|
[NCBI]
|
4.22493e-05
|
|
|
EGFL6
|
[NCBI]
|
4.22493e-05
|
|
|
TIMM44
|
[NCBI]
|
4.22493e-05
|
|
|
PCDH19
|
[NCBI]
|
4.22493e-05
|
|
|
SFPQ
|
[NCBI]
|
4.22493e-05
|
|
|
PDHA2
|
[NCBI]
|
4.22493e-05
|
|
|
TDRD1
|
[NCBI]
|
4.22493e-05
|
|
|
ITGB1BP2
|
[NCBI]
|
4.22493e-05
|
|
|
BRCC3
|
[NCBI]
|
4.22493e-05
|
|
|
P2RY4
|
[NCBI]
|
4.22493e-05
|
|
|
SAGE1
|
[NCBI]
|
4.22493e-05
|
|
|
CA5B
|
[NCBI]
|
4.22493e-05
|
|
|
MAGEB5
|
[NCBI]
|
4.22493e-05
|
|
|
TMSB4Y
|
[NCBI]
|
4.22493e-05
|
|
|
PJA1
|
[NCBI]
|
4.22493e-05
|
|
|
INPP5A
|
[NCBI]
|
4.22493e-05
|
|
|
ARMCX2
|
[NCBI]
|
4.22493e-05
|
|
|
IQSEC2
|
[NCBI]
|
4.22493e-05
|
|
|
PCDH10
|
[NCBI]
|
4.22493e-05
|
|
|
MAGEC3
|
[NCBI]
|
4.22493e-05
|
|
|
GSPT2
|
[NCBI]
|
4.22493e-05
|
|
|
GAGE7B
|
[NCBI]
|
4.22493e-05
|
|
|
prostate cancer
|
[NCBI]
|
4.11973e-05
|
|
|
HSCR1
|
[NCBI]
|
4.07584e-05
|
|
|
fragile site 2q11
|
[NCBI]
|
4.06617e-05
|
|
|
mental health wellness 2
|
[NCBI]
|
4.06617e-05
|
|
|
arthrogryposis, renal dysfunction, and cholestasis
|
[NCBI]
|
3.98114e-05
|
|
|
myopathy, centronuclear, autosomal dominant
|
[NCBI]
|
3.98114e-05
|
|
|
CMT1A
|
[NCBI]
|
3.93064e-05
|
|
|
PPP6C
|
[NCBI]
|
3.9191e-05
|
|
|
UBQLN2
|
[NCBI]
|
3.9191e-05
|
|
|
PCTK3
|
[NCBI]
|
3.9191e-05
|
|
|
USP26
|
[NCBI]
|
3.9191e-05
|
|
|
ODZ4
|
[NCBI]
|
3.9191e-05
|
|
|
BEX2
|
[NCBI]
|
3.9191e-05
|
|
|
MYBL1
|
[NCBI]
|
3.9191e-05
|
|
|
GAGED2
|
[NCBI]
|
3.9191e-05
|
|
|
PLS3
|
[NCBI]
|
3.9191e-05
|
|
|
SLOS
|
[NCBI]
|
3.88191e-05
|
|
|
ASMT
|
[NCBI]
|
3.85613e-05
|
|
|
FIGF
|
[NCBI]
|
3.85613e-05
|
|
|
SLC25A14
|
[NCBI]
|
3.85613e-05
|
|
|
RPS6KA6
|
[NCBI]
|
3.85613e-05
|
|
|
TIMM23
|
[NCBI]
|
3.85613e-05
|
|
|
TRPM6
|
[NCBI]
|
3.72241e-05
|
|
|
agammaglobulinemia, non-bruton type, autosomal recessive
|
[NCBI]
|
3.69899e-05
|
|
|
radioulnar synostosis
|
[NCBI]
|
3.69899e-05
|
|
|
COMT
|
[NCBI]
|
3.69454e-05
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-negative
|
[NCBI]
|
3.63453e-05
|
|
|
OPTB1
|
[NCBI]
|
3.61823e-05
|
|
|
RB1
|
[NCBI]
|
3.57963e-05
|
|
|
PHF6
|
[NCBI]
|
3.57756e-05
|
|
|
UBE2A
|
[NCBI]
|
3.57756e-05
|
|
|
mst3- and sok1-related kinase
|
[NCBI]
|
3.5503e-05
|
|
|
SLC35A2
|
[NCBI]
|
3.5503e-05
|
|
|
prader-willi/angelman region 1
|
[NCBI]
|
3.5503e-05
|
|
|
ZNF41
|
[NCBI]
|
3.5503e-05
|
|
|
GPR23
|
[NCBI]
|
3.5503e-05
|
|
|
MAGEA11
|
[NCBI]
|
3.5503e-05
|
|
|
MAGEA12
|
[NCBI]
|
3.5503e-05
|
|
|
PLP2
|
[NCBI]
|
3.5503e-05
|
|
|
PPEF1
|
[NCBI]
|
3.5503e-05
|
|
|
actin-binding protein, 34-kd
|
[NCBI]
|
3.5503e-05
|
|
|
ODZ2
|
[NCBI]
|
3.5503e-05
|
|
|
MAGEA3
|
[NCBI]
|
3.5503e-05
|
|
|
RBM10
|
[NCBI]
|
3.5503e-05
|
|
|
PWCR1
|
[NCBI]
|
3.5503e-05
|
|
|
NSBP1
|
[NCBI]
|
3.5503e-05
|
|
|
IPW
|
[NCBI]
|
3.5503e-05
|
|
|
CTAG2
|
[NCBI]
|
3.5503e-05
|
|
|
MCTS1
|
[NCBI]
|
3.5503e-05
|
|
|
TCEAL1
|
[NCBI]
|
3.5503e-05
|
|
|
MAGEA10
|
[NCBI]
|
3.5503e-05
|
|
|
TEX14
|
[NCBI]
|
3.5503e-05
|
|
|
AKAP4
|
[NCBI]
|
3.5503e-05
|
|
|
PRY2
|
[NCBI]
|
3.5503e-05
|
|
|
PNPLA4
|
[NCBI]
|
3.5503e-05
|
|
|
GABRE
|
[NCBI]
|
3.5503e-05
|
|
|
PCDH18
|
[NCBI]
|
3.5503e-05
|
|
|
MAGEC1
|
[NCBI]
|
3.5503e-05
|
|
|
PLXNA3
|
[NCBI]
|
3.5503e-05
|
|
|
MAGEA6
|
[NCBI]
|
3.5503e-05
|
|
|
TRPC5
|
[NCBI]
|
3.5503e-05
|
|
|
MAGEA9
|
[NCBI]
|
3.5503e-05
|
|
|
ACH
|
[NCBI]
|
3.48199e-05
|
|
|
prostate cancer/brain cancer susceptibility
|
[NCBI]
|
3.46512e-05
|
|
|
HYR
|
[NCBI]
|
3.46512e-05
|
|
|
H3F3A
|
[NCBI]
|
3.4283e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
3.428012e-05
|
|
|
PIGF
|
[NCBI]
|
3.35361e-05
|
|
|
ODZ1
|
[NCBI]
|
3.35361e-05
|
|
|
PA2G4
|
[NCBI]
|
3.35361e-05
|
|
|
IGBP1
|
[NCBI]
|
3.35361e-05
|
|
|
FKBP6
|
[NCBI]
|
3.35361e-05
|
|
|
SOX1
|
[NCBI]
|
3.35361e-05
|
|
|
UTY
|
[NCBI]
|
3.35361e-05
|
|
|
CRSP2
|
[NCBI]
|
3.35361e-05
|
|
|
ERAS
|
[NCBI]
|
3.35361e-05
|
|
|
SPG6
|
[NCBI]
|
3.31742e-05
|
|
|
OCD1
|
[NCBI]
|
3.31742e-05
|
|
|
MAGEA4
|
[NCBI]
|
3.31361e-05
|
|
|
FDPS
|
[NCBI]
|
3.31361e-05
|
|
|
CD48
|
[NCBI]
|
3.31361e-05
|
|
|
BMP15
|
[NCBI]
|
3.29874e-05
|
|
|
dyskeratosis congenita, autosomal dominant
|
[NCBI]
|
3.26735e-05
|
|
|
MUC1
|
[NCBI]
|
3.22536e-05
|
|
|
coffin-siris syndrome
|
[NCBI]
|
3.219749e-05
|
|
|
ELK4
|
[NCBI]
|
3.20876e-05
|
|
|
PRIM1
|
[NCBI]
|
3.20876e-05
|
|
|
PDHB
|
[NCBI]
|
3.20876e-05
|
|
|
PHF8
|
[NCBI]
|
3.20876e-05
|
|
|
VSIG4
|
[NCBI]
|
3.20876e-05
|
|
|
GSPT1
|
[NCBI]
|
3.20876e-05
|
|
|
EDARADD
|
[NCBI]
|
3.20876e-05
|
|
|
EEF1B2
|
[NCBI]
|
3.20876e-05
|
|
|
HBB
|
[NCBI]
|
3.173664e-05
|
|
|
frontonasal dysplasia
|
[NCBI]
|
3.15224e-05
|
|
|
FRDA
|
[NCBI]
|
3.14395e-05
|
|
|
DRP2
|
[NCBI]
|
3.13967e-05
|
|
|
PRY
|
[NCBI]
|
3.11692e-05
|
|
|
ARR3
|
[NCBI]
|
3.11692e-05
|
|
|
GUCY2F
|
[NCBI]
|
3.11692e-05
|
|
|
NDUFA1
|
[NCBI]
|
3.11692e-05
|
|
|
RNF12
|
[NCBI]
|
3.11692e-05
|
|
|
CITED1
|
[NCBI]
|
3.11692e-05
|
|
|
ATP2B3
|
[NCBI]
|
3.11692e-05
|
|
|
SH3KBP1
|
[NCBI]
|
3.11692e-05
|
|
|
PLXNA1
|
[NCBI]
|
3.11692e-05
|
|
|
MAGEA2
|
[NCBI]
|
3.11692e-05
|
|
|
RAB9
|
[NCBI]
|
3.11692e-05
|
|
|
NXF2
|
[NCBI]
|
3.11692e-05
|
|
|
EIF1AX
|
[NCBI]
|
3.11692e-05
|
|
|
FPLD2
|
[NCBI]
|
3.08834e-05
|
|
|
autoimmune disease
|
[NCBI]
|
3.074535e-05
|
|
|
EV
|
[NCBI]
|
3.04068e-05
|
|
|
DHH
|
[NCBI]
|
2.98189e-05
|
|
|
langer mesomelic dysplasia
|
[NCBI]
|
2.973595e-05
|
|
|
MEA1
|
[NCBI]
|
2.97207e-05
|
|
|
MAGEE1
|
[NCBI]
|
2.97207e-05
|
|
|
MYBL2
|
[NCBI]
|
2.97207e-05
|
|
|
piwi-like 2: piwil2
|
[NCBI]
|
2.97207e-05
|
|
|
PLXNA2
|
[NCBI]
|
2.97207e-05
|
|
|
TSTA3
|
[NCBI]
|
2.97207e-05
|
|
|
MAGED1
|
[NCBI]
|
2.97207e-05
|
|
|
ALAS1
|
[NCBI]
|
2.97207e-05
|
|
|
GPM6A
|
[NCBI]
|
2.97207e-05
|
|
|
CRLF2
|
[NCBI]
|
2.97207e-05
|
|
|
WSS
|
[NCBI]
|
2.95024e-05
|
|
|
DFNA12
|
[NCBI]
|
2.95024e-05
|
|
|
AIH2
|
[NCBI]
|
2.91837e-05
|
|
|
GPR44
|
[NCBI]
|
2.79813e-05
|
|
|
H2AFY
|
[NCBI]
|
2.79813e-05
|
|
|
KIF4A
|
[NCBI]
|
2.79813e-05
|
|
|
UPF3B
|
[NCBI]
|
2.79813e-05
|
|
|
MTMR3
|
[NCBI]
|
2.79813e-05
|
|
|
AP1S2
|
[NCBI]
|
2.79813e-05
|
|
|
RBM3
|
[NCBI]
|
2.79813e-05
|
|
|
DCAMKL1
|
[NCBI]
|
2.79813e-05
|
|
|
DIAPH1
|
[NCBI]
|
2.79813e-05
|
|
|
BPP
|
[NCBI]
|
2.71016e-05
|
|
|
CA5A
|
[NCBI]
|
2.68381e-05
|
|
|
HMCN1
|
[NCBI]
|
2.68381e-05
|
|
|
CDY1
|
[NCBI]
|
2.68381e-05
|
|
|
HELLS
|
[NCBI]
|
2.68381e-05
|
|
|
BCOR
|
[NCBI]
|
2.68381e-05
|
|
|
phosphoglycerate kinase 1 deficiency
|
[NCBI]
|
2.65134e-05
|
|
|
XRCC3
|
[NCBI]
|
2.58966e-05
|
|
|
PCDH8
|
[NCBI]
|
2.54682e-05
|
|
|
IL13RA2
|
[NCBI]
|
2.54682e-05
|
|
|
UBE2B
|
[NCBI]
|
2.54682e-05
|
|
|
precursor mrna-processing factor 3, s. cerevisiae, homolog of
|
[NCBI]
|
2.54682e-05
|
|
|
ATOX1
|
[NCBI]
|
2.54682e-05
|
|
|
RDX
|
[NCBI]
|
2.54682e-05
|
|
|
bkm dna
|
[NCBI]
|
2.54682e-05
|
|
|
MS
|
[NCBI]
|
2.530933e-05
|
|
|
nondisjunction
|
[NCBI]
|
2.516514e-05
|
|
|
ETM1
|
[NCBI]
|
2.509712e-05
|
|
|
PLXNB1
|
[NCBI]
|
2.43426e-05
|
|
|
FXR2
|
[NCBI]
|
2.43426e-05
|
|
|
cutis laxa, autosomal recessive, type ii
|
[NCBI]
|
2.408455e-05
|
|
|
CDKL5
|
[NCBI]
|
2.379986e-05
|
|
|
SRD5A1
|
[NCBI]
|
2.37286e-05
|
|
|
BIRC3
|
[NCBI]
|
2.37286e-05
|
|
|
IL13RA1
|
[NCBI]
|
2.34011e-05
|
|
|
SLC25A5
|
[NCBI]
|
2.34011e-05
|
|
|
PHKB
|
[NCBI]
|
2.34011e-05
|
|
|
ABCD2
|
[NCBI]
|
2.34011e-05
|
|
|
ITM2A
|
[NCBI]
|
2.34011e-05
|
|
|
chromosome 17q21.31 microdeletion syndrome
|
[NCBI]
|
2.34011e-05
|
|
|
RCDP1
|
[NCBI]
|
2.312899e-05
|
|
|
CYSLTR1
|
[NCBI]
|
2.303765e-05
|
|
|
PMP22
|
[NCBI]
|
2.3004e-05
|
|
|
GAPDH
|
[NCBI]
|
2.27031e-05
|
|
|
DMRT1
|
[NCBI]
|
2.2603e-05
|
|
|
FLNC
|
[NCBI]
|
2.2603e-05
|
|
|
BIRC2
|
[NCBI]
|
2.2603e-05
|
|
|
EED
|
[NCBI]
|
2.2603e-05
|
|
|
PSPH
|
[NCBI]
|
2.2603e-05
|
|
|
SAT1
|
[NCBI]
|
2.2603e-05
|
|
|
VDAC2
|
[NCBI]
|
2.2449e-05
|
|
|
gracile syndrome
|
[NCBI]
|
2.19528e-05
|
|
|
ornithine aminotransferase deficiency
|
[NCBI]
|
2.19448e-05
|
|
|
MAG
|
[NCBI]
|
2.172596e-05
|
|
|
epstein syndrome
|
[NCBI]
|
2.166079e-05
|
|
|
UXT
|
[NCBI]
|
2.16509e-05
|
|
|
OGT
|
[NCBI]
|
2.16509e-05
|
|
|
GRIA4
|
[NCBI]
|
2.16509e-05
|
|
|
EDAR
|
[NCBI]
|
2.130436e-05
|
|
|
TDGF1
|
[NCBI]
|
2.095995e-05
|
|
|
ARD1A
|
[NCBI]
|
2.095995e-05
|
|
|
ACE2
|
[NCBI]
|
2.035226e-05
|
|
|
SHC1
|
[NCBI]
|
2.035226e-05
|
|
|
corpus callosum, agenesis of
|
[NCBI]
|
2.018719e-05
|
|
|
ichthyosis vulgaris
|
[NCBI]
|
2.018719e-05
|
|
|
HTR2C
|
[NCBI]
|
2.013765e-05
|
|
|
CD81
|
[NCBI]
|
2.013765e-05
|
|
|
AK3
|
[NCBI]
|
2.013765e-05
|
|
|
CENPC1
|
[NCBI]
|
2.013765e-05
|
|
|
IDH2
|
[NCBI]
|
2.013765e-05
|
|
|
TTR
|
[NCBI]
|
1.981368e-05
|
|
|
SYCP3
|
[NCBI]
|
1.952996e-05
|
|
|
FGF6
|
[NCBI]
|
1.898874e-05
|
|
|
ATP2B2
|
[NCBI]
|
1.898874e-05
|
|
|
LGMD2D
|
[NCBI]
|
1.889659e-05
|
|
|
EMT
|
[NCBI]
|
1.880838e-05
|
|
|
FXR1
|
[NCBI]
|
1.880838e-05
|
|
|
VDAC1
|
[NCBI]
|
1.877495e-05
|
|
|
BLMH
|
[NCBI]
|
1.847914e-05
|
|
|
DAZ
|
[NCBI]
|
1.847804e-05
|
|
|
wilson disease
|
[NCBI]
|
1.838106e-05
|
|
|
WARS
|
[NCBI]
|
1.826716e-05
|
|
|
NODAL
|
[NCBI]
|
1.826716e-05
|
|
|
MDM1
|
[NCBI]
|
1.826716e-05
|
|
|
COL4A4
|
[NCBI]
|
1.778028e-05
|
|
|
APOA2
|
[NCBI]
|
1.776634e-05
|
|
|
denys-drash syndrome
|
[NCBI]
|
1.775834e-05
|
|
|
ACO2
|
[NCBI]
|
1.762604e-05
|
|
|
HHS
|
[NCBI]
|
1.73898e-05
|
|
|
sertoli cell-only syndrome, y-linked
|
[NCBI]
|
1.73898e-05
|
|
|
PSG1
|
[NCBI]
|
1.733864e-05
|
|
|
ETF1
|
[NCBI]
|
1.728624e-05
|
|
|
EZH2
|
[NCBI]
|
1.669752e-05
|
|
|
YY1
|
[NCBI]
|
1.656466e-05
|
|
|
LAMR1
|
[NCBI]
|
1.629414e-05
|
|
|
NCIE1
|
[NCBI]
|
1.625155e-05
|
|
|
ZNF198
|
[NCBI]
|
1.612217e-05
|
|
|
GJA4
|
[NCBI]
|
1.560966e-05
|
|
|
GLRA1
|
[NCBI]
|
1.533368e-05
|
|
|
feingold syndrome
|
[NCBI]
|
1.532706e-05
|
|
|
ACHM2
|
[NCBI]
|
1.524215e-05
|
|
|
TCL1A
|
[NCBI]
|
1.519821e-05
|
|
|
NAGA
|
[NCBI]
|
1.519821e-05
|
|
|
CRB1
|
[NCBI]
|
1.500599e-05
|
|
|
ZS
|
[NCBI]
|
1.4997438e-05
|
|
|
CES
|
[NCBI]
|
1.498467e-05
|
|
|
ACO1
|
[NCBI]
|
1.482761e-05
|
|
|
AHCY
|
[NCBI]
|
1.482761e-05
|
|
|
TPO
|
[NCBI]
|
1.481146e-05
|
|
|
GOT1
|
[NCBI]
|
1.472395e-05
|
|
|
SGCA
|
[NCBI]
|
1.468863e-05
|
|
|
GDAP1
|
[NCBI]
|
1.448541e-05
|
|
|
CYP11A1
|
[NCBI]
|
1.439319e-05
|
|
|
MTMR2
|
[NCBI]
|
1.435335e-05
|
|
|
vitamin d-dependent rickets, type i
|
[NCBI]
|
1.434314e-05
|
|
|
SCZD4
|
[NCBI]
|
1.434314e-05
|
|
|
MB
|
[NCBI]
|
1.401516e-05
|
|
|
LDHC
|
[NCBI]
|
1.401115e-05
|
|
|
RAB27A
|
[NCBI]
|
1.401115e-05
|
|
|
SDC1
|
[NCBI]
|
1.401115e-05
|
|
|
ACCPN
|
[NCBI]
|
1.385116e-05
|
|
|
asthma, susceptibility to
|
[NCBI]
|
1.384595e-05
|
|
|
CYBA
|
[NCBI]
|
1.369379e-05
|
|
|
danubian endemic familial nephropathy
|
[NCBI]
|
1.359926e-05
|
|
|
PIK3R1
|
[NCBI]
|
1.357656e-05
|
|
|
PAX3
|
[NCBI]
|
1.33205e-05
|
|
|
HP
|
[NCBI]
|
1.327902e-05
|
|
|
NCF1
|
[NCBI]
|
1.32592e-05
|
|
|
JAK3
|
[NCBI]
|
1.312825e-05
|
|
|
BLM
|
[NCBI]
|
1.307373e-05
|
|
|
CRS1
|
[NCBI]
|
1.305184e-05
|
|
|
chondrodysplasia punctata, autosomal dominant
|
[NCBI]
|
1.289821e-05
|
|
|
HDAC6
|
[NCBI]
|
1.286382e-05
|
|
|
TERF1
|
[NCBI]
|
1.285899e-05
|
|
|
LRE1
|
[NCBI]
|
1.265072e-05
|
|
|
abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism
|
[NCBI]
|
1.251939e-05
|
|
|
GJA3
|
[NCBI]
|
1.228757e-05
|
|
|
SPG7
|
[NCBI]
|
1.228757e-05
|
|
|
JMML
|
[NCBI]
|
1.226604e-05
|
|
|
UTRN
|
[NCBI]
|
1.214524e-05
|
|
|
NR5A1
|
[NCBI]
|
1.205501e-05
|
|
|
NS1
|
[NCBI]
|
1.205295e-05
|
|
|
PNMT
|
[NCBI]
|
1.198535e-05
|
|
|
GLUD1
|
[NCBI]
|
1.191743e-05
|
|
|
AVSD
|
[NCBI]
|
1.171233e-05
|
|
|
KAL2
|
[NCBI]
|
1.159382e-05
|
|
|
CD40
|
[NCBI]
|
1.157382e-05
|
|
|
ACTA1
|
[NCBI]
|
1.157382e-05
|
|
|
NR3C2
|
[NCBI]
|
1.153784e-05
|
|
|
d-bifunctional protein deficiency
|
[NCBI]
|
1.138114e-05
|
|
|
CPI
|
[NCBI]
|
1.104695e-05
|
|
|
NR4A3
|
[NCBI]
|
1.075236e-05
|
|
|
KCNA1
|
[NCBI]
|
1.058692e-05
|
|
|
LCP1
|
[NCBI]
|
1.045341e-05
|
|
|
SPCH1
|
[NCBI]
|
1.041966e-05
|
|
|
SDC2
|
[NCBI]
|
1.039739e-05
|
|
|
DLD
|
[NCBI]
|
1.010384e-05
|
|
|
SCZD
|
[NCBI]
|
9.914342e-06
|
|
|
PDCD8
|
[NCBI]
|
9.62914e-06
|
|
|
ATR
|
[NCBI]
|
9.52492e-06
|
|
|
danon disease
|
[NCBI]
|
9.47273e-06
|
|
|
MTRNR1
|
[NCBI]
|
9.33076e-06
|
|
|
DRPLA
|
[NCBI]
|
9.27796e-06
|
|
|
RPS19
|
[NCBI]
|
9.14836e-06
|
|
|
breast cancer
|
[NCBI]
|
8.4717726e-06
|
|
|
LDHB
|
[NCBI]
|
8.4642e-06
|
|
|
musical perfect pitch
|
[NCBI]
|
8.450344e-06
|
|
|
FTL
|
[NCBI]
|
8.36816e-06
|
|
|
CACNA1C
|
[NCBI]
|
8.23125e-06
|
|
|
LNS
|
[NCBI]
|
8.081015e-06
|
|
|
hypertension, essential
|
[NCBI]
|
8.01324e-06
|
|
|
ACOX1
|
[NCBI]
|
7.96415e-06
|
|
|
ASS
|
[NCBI]
|
7.70168e-06
|
|
|
COL4A3
|
[NCBI]
|
7.63779e-06
|
|
|
AFD1
|
[NCBI]
|
7.57213e-06
|
|
|
ARSB
|
[NCBI]
|
7.53741e-06
|
|
|
ATF4
|
[NCBI]
|
7.47999e-06
|
|
|
HRPT1
|
[NCBI]
|
7.42278e-06
|
|
|
TLR7
|
[NCBI]
|
7.42016e-06
|
|
|
hypogonadotropic hypogonadism
|
[NCBI]
|
7.38014e-06
|
|
|
SOD1
|
[NCBI]
|
7.18042e-06
|
|
|
BRAF
|
[NCBI]
|
7.15516e-06
|
|
|
MTTK
|
[NCBI]
|
6.76418e-06
|
|
|
GJA5
|
[NCBI]
|
6.74953e-06
|
|
|
HD
|
[NCBI]
|
6.65107e-06
|
|
|
ETV6
|
[NCBI]
|
6.62559e-06
|
|
|
UNG
|
[NCBI]
|
6.49639e-06
|
|
|
GPX1
|
[NCBI]
|
6.43964e-06
|
|
|
AK1
|
[NCBI]
|
6.35714e-06
|
|
|
PFM
|
[NCBI]
|
6.315718e-06
|
|
|
infantile sialic acid storage disorder
|
[NCBI]
|
6.315718e-06
|
|
|
SOX10
|
[NCBI]
|
6.28826e-06
|
|
|
WS1
|
[NCBI]
|
6.12068e-06
|
|
|
DCN
|
[NCBI]
|
5.8771e-06
|
|
|
RAC1
|
[NCBI]
|
5.75151e-06
|
|
|
adrenoleukodystrophy, autosomal neonatal form
|
[NCBI]
|
5.630681e-06
|
|
|
GJA1
|
[NCBI]
|
5.57299e-06
|
|
|
MTATP6
|
[NCBI]
|
5.48047e-06
|
|
|
HDGF
|
[NCBI]
|
5.41153e-06
|
|
|
aortic aneurysm, abdominal
|
[NCBI]
|
5.31182e-06
|
|
|
CBAVD
|
[NCBI]
|
5.20693e-06
|
|
|
GAMT
|
[NCBI]
|
5.15767e-06
|
|
|
FCMD
|
[NCBI]
|
5.036825e-06
|
|
|
TSC1
|
[NCBI]
|
5.02794e-06
|
|
|
SLAMF1
|
[NCBI]
|
4.99099e-06
|
|
|
HEXB
|
[NCBI]
|
4.6641e-06
|
|
|
SNRPN
|
[NCBI]
|
4.63236e-06
|
|
|
GRIA2
|
[NCBI]
|
4.55968e-06
|
|
|
spermatogenic failure, nonobstructive, y-linked
|
[NCBI]
|
4.424644e-06
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-positive
|
[NCBI]
|
4.340717e-06
|
|
|
DBA
|
[NCBI]
|
4.33678e-06
|
|
|
SMA3
|
[NCBI]
|
4.2478708e-06
|
|
|
mycobacterium tuberculosis, susceptibility to
|
[NCBI]
|
4.096988e-06
|
|
|
REN
|
[NCBI]
|
3.954952e-06
|
|
|
graves disease
|
[NCBI]
|
3.939369e-06
|
|
|
GALT
|
[NCBI]
|
3.86051e-06
|
|
|
FGF23
|
[NCBI]
|
3.82553e-06
|
|
|
ADA
|
[NCBI]
|
3.554722e-06
|
|
|
methemoglobinemia due to deficiency of methemoglobin reductase
|
[NCBI]
|
3.48751e-06
|
|
|
CREBBP
|
[NCBI]
|
3.28331e-06
|
|
|
KCNQ1
|
[NCBI]
|
3.255114e-06
|
|
|
hypertrophic neuropathy of dejerine-sottas
|
[NCBI]
|
3.236755e-06
|
|
|
ST3
|
[NCBI]
|
3.141873e-06
|
|
|
CMT1B
|
[NCBI]
|
3.129553e-06
|
|
|
EFE
|
[NCBI]
|
3.07965e-06
|
|
|
usher syndrome, type i
|
[NCBI]
|
2.984934e-06
|
|
|
sialuria, finnish type
|
[NCBI]
|
2.958178e-06
|
|
|
holoprosencephaly
|
[NCBI]
|
2.81097e-06
|
|
|
ARSA
|
[NCBI]
|
2.777601e-06
|
|
|
TSC2
|
[NCBI]
|
2.725891e-06
|
|
|
RSTS
|
[NCBI]
|
2.6966114e-06
|
|
|
MSD
|
[NCBI]
|
2.542703e-06
|
|
|
MADD
|
[NCBI]
|
2.420996e-06
|
|
|
campomelic dysplasia
|
[NCBI]
|
2.3621147e-06
|
|
|
SPG3A
|
[NCBI]
|
2.304625e-06
|
|
|
WT1
|
[NCBI]
|
2.183443e-06
|
|
|
neuroblastoma
|
[NCBI]
|
2.148513e-06
|
|
|
NP
|
[NCBI]
|
2.129075e-06
|
|
|
BRCA1
|
[NCBI]
|
2.0227802e-06
|
|
|
BPES
|
[NCBI]
|
1.918127e-06
|
|
|
DNMT1
|
[NCBI]
|
1.739715e-06
|
|
|
lipomatosis, multiple
|
[NCBI]
|
1.65993268e-06
|
|
|
AMH
|
[NCBI]
|
1.5468e-06
|
|
|
LS
|
[NCBI]
|
1.5457721e-06
|
|
|
PARK2
|
[NCBI]
|
1.383145e-06
|
|
|
COL1A2
|
[NCBI]
|
1.3369474e-06
|
|
|
FSHR
|
[NCBI]
|
1.305062e-06
|
|
|
alzheimer disease 3
|
[NCBI]
|
1.259569e-06
|
|
|
GJB2
|
[NCBI]
|
1.2216509e-06
|
|
|
IDUA
|
[NCBI]
|
9.86978e-07
|
|
|
CBX5
|
[NCBI]
|
9.59909e-07
|
|
|
AQP2
|
[NCBI]
|
9.1015e-07
|
|
|
von willebrand disease
|
[NCBI]
|
8.594807e-07
|
|
|
GPT
|
[NCBI]
|
8.39438e-07
|
|
|
immunodeficiency-centromeric instability-facial anomalies syndrome
|
[NCBI]
|
7.80512e-07
|
|
|
NR0B2
|
[NCBI]
|
7.27644e-07
|
|
|
TBS
|
[NCBI]
|
7.245777e-07
|
|
|
mitochondrial complex i deficiency
|
[NCBI]
|
7.245777e-07
|
|
|
STAR
|
[NCBI]
|
4.041532305e-07
|
|
|
MPZ
|
[NCBI]
|
3.996887e-07
|
|
|
myeloproliferative syndrome, transient
|
[NCBI]
|
3.8964568e-07
|
|
|
CMD1A
|
[NCBI]
|
3.12655e-07
|
|
|
NF1
|
[NCBI]
|
3.014737365e-07
|
|
|
ZFP36
|
[NCBI]
|
2.31343e-07
|
|
|
PTN
|
[NCBI]
|
2.11382e-07
|
|
|
DDC
|
[NCBI]
|
1.899973605e-07
|
|
|
myoclonic epilepsy of unverricht and lundborg
|
[NCBI]
|
1.863518245e-07
|
|
|
alopecia, androgenetic
|
[NCBI]
|
1.819137e-07
|
|
|
OCA1A
|
[NCBI]
|
8.63403e-08
|
|
|
GRP
|
[NCBI]
|
6.06378e-08
|
|
|
CDG1A
|
[NCBI]
|
8.293567e-09
|
|